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the	 aetiology	of	 otitis	media	with	 effusion.	Otitis	media	 and	otitis	media	with	 effusion	have	been	
classically	associated	with	three	main	bacteria,	Streptococcus	pneumoniae,	Haemophilus	 influenzae	
and	 Moraxella	 catarrhalis.	 However,	 with	 advancements	 in	 culture-independent	 molecular	
techniques,	 previously	 un-culturable	 bacteria	 have	 been	 identified.	 Moreover,	 using	 these	








We	 found	 that	 the	microbial	 communities	within	 the	middle	 ear	 and	 on	 the	 adenoid	 pad	 shared	
some	 common	 bacteria;	 however,	 we	 also	 discovered	 the	 presence	 of	 bacteria	 not	 found	 in	 the	















A.	 otitidis	 and	 is	 the	 subject	 of	 chapter	 4.	 Otitis	media	with	 effusion	 has	 been	 suggested	 to	 be	 a	
biofilm	driven	disease.	Therefore,	we	sought	to	discover	whether	A.	otitidis	forms	biofilm.	We	found	
that	not	only	does	A.	otitidis	form	single	species	biofilm,	but	that	it	also	forms	polymicrobial	biofilm	
with	H.	 influenzae.	 The	 subsequent	 polymicrobial	 biofilm	 allowed	 the	 bacteria	 to	 express	 a	 new	



































































































































































































It	 is	 likely	 that	 humans	 have	 always	 suffered	 from	 infections	 of	 the	middle	 ear	 and	 its	 associated	
sequelae.	Evidence	of	perforations	of	the	tympanic	membrane	and	destruction	of	the	mastoid	were	
identified	 in	 2600	 year	 old	 Egyptian	mummies1.	 Today,	 otitis	media	 continues	 to	 be	 a	worldwide	
problem	 for	 children.	Otitis	media	 (OM)	 refers	 to	 a	 spectrum	of	 disease	 involving	 the	middle	 ear;	
however,	its	nomenclature	and	classification	have	changed	over	the	years.	
Acute	otitis	media	(AOM)	represents	acute	suppurative	inflammation	of	the	middle	ear.	It	manifests	
with	 local	 symptoms	 of	 otalgia	 and	 otorrhea	 and	 can	 be	 associated	 with	 systemic	 symptoms	
including	 fever,	 irritability,	 anorexia,	 nausea,	 vomiting	 and	 even	 diarrhoea.	 In	 AOM	 without	
perforation,	 the	 tympanic	 membrane	 bulges	 into	 the	 external	 auditory	 canal	 and	 often	 appears	
opaque,	 with	 reduced	 mobility	 of	 the	 tympanic	 membrane	 upon	 pneumatic	 otoscopy.	 Recurrent	
AOM	(rAOM)	is	defined	as	multiple	discreet	episodes	of	AOM,	with	greater	than	three	episodes	in	6	
months,	or	greater	than	4	 in	12	months2.	 rAOM	is	further	distinguished	 into	two	categories:	acute	
infection	 with	 total	 resolution	 of	 middle	 ear	 fluid	 between	 attacks	 and	 those	 with	 AOM	 with	
underlying	 persistent	 otitis	 media	 with	 effusion	 (OME).	 Also,	 acute	 otitis	 media	 can	 result	 in	 a	
perforation	of	the	tympanic	membrane	in	up	to	30%	of	cases3.	AOM	with	perforation	describes	AOM	
resulting	in	the	rupture	tympanic	membrane,	with	subsequent	discharge	from	the	middle	ear	within	
7	 days	 of	 infection2.	 Furthermore,	 for	 patients	with	 existing	 tympanostomy	 tubes	 (also	 known	 as	
“grommets”	 or	 ventilation	 tubes),	 AOM	 resulting	 in	 otorrhea	 is	 also	 classified	 as	 AOM	 with	









the	 past.	However,	 despite	 the	 absence	 of	 the	 acute	 ear,	 OME	 is	 associated	 with	 significant	
sequelae.	 It	 is	 the	 commonest	 cause	 of	 deafness4	 and	 balance	 disorder	 in	 childhood5,	 and	 may		
result	in		development	delays	and	behaviour	changes.	Examination	of	the	middle	ear	with	pneumatic	












the	age	of	 five.	Whilst	 these	 figures	 represent	episodes	of	AOM,	 it	has	been	reported	that	45%	of	
children	with	AOM	have	 a	persistent	middle	 ear	 effusion	 at	 1	month	 and	10%	at	 3	months6.	 This	
suggests	that	in	Australia,	close	to	a	quarter	of	a	million	children	will	have	OME	each	year.	
1.1.3 Aetiology	and	pathogenesis	















As	discussed	above,	 the	 incidence	of	OME	 is	associated	with	age.	 In	addition,	gender	plays	a	 role,	
with	a	higher	preponderance	for	boys	to	suffer	from	otitis	media6.	Furthermore,	genetic	factors	are	
associated	with	 otitis	media:	 in	 a	 Norwegian	 study	 of	 twin	 pairs,	 it	 was	 demonstrated	 that	 otitis	
media	could	be	inherited,	with	a	74%	heritability	of	OM	in	girls	and	45%	in	boys10.	Likewise,	the	HLA-





glycoproteins	 that	 make	 up	 8-32%	 of	 non-dialysable	 solids	 within	 effusions	 samples4	 and	 are	
responsible	 for	 the	 viscous	 and	 gel-like	 nature	 of	 middle	 ear	 effusions.	 Higher	 concentrations	 of	







In	 addition,	 heritable	 diseases	 that	 affect	 mucociliary	 clearance	 can	 lead	 to	 OME.	 For	 instance,	
patients	 with	 primary	 ciliary	 dyskinesia,	 a	 hereditary	 defect	 in	 the	 ultrastructure	 of	 ciliated	





to	 the	nasopharynx	and	 shares	a	 common	embryological	origin	with	 the	middle	ear	 from	 the	 first	
branchial	pocket	15.	It	is	lined	with	respiratory	epithelium,	and	its	role	is	to	help	ventilate	the	ear	via	
direct	clearance	of	middle	ear	 fluid	and	 to	also	maintain	 the	pressure	gradient	between	the	outer	
and	middle	 ears.	 Compared	with	 adults,	 the	 orientation	 of	 the	 ET	 in	 children	 is	more	 horizontal,	







due	 to	 the	 negative	 pressure.	 However,	 this	 theory	 has	 some	 flaws,	 including	 that	 the	 effusion	
within	the	middle	ear	is	often	an	actively	secreted	exudate	and	that	the	model	does	not	adequately	
explain	the	inflammation	and	metaplasia	associated	with	OME18.		
















Otitis	media	with	effusion	affects	92-97%	of	children	with	cleft	palate	 in	 their	 first	year	of	 life	and	
persists	 in	70%	of	 these	children	at	age	425,26.	 The	mechanism	behind	 this	high	 incidence	 is	again	
thought	 to	 be	 ET	 dysfunction.	 The	 tensor	 and	 levator	 palatine	 muscles	 originate	 from	 the	
cartilaginous	ET	and	 insert	 into	 the	 soft	palate.	However,	 the	midline	 raphae	are	deficient	 in	 cleft	
palate,	which	subsequently	results	in	the	ineffective	opening	of	the	ET27.	 In	addition,	there	is	likely	
an	 impaired	middle	 ear	 immune	 defence	 system	 as	 children	with	 cleft	 palate	 have	 effusions	with	




with	 the	 upper	 aerodigestive	 tract.	 As	 discussed	 above,	 due	 to	 ET	 angulation	 and	 functional	






digestive	 enzymes	 of	 the	 stomach	 and	 have	 been	 used	 as	 an	 indirect	marker	 of	 reflux	 of	 gastric	
material	 into	 the	middle	 ear,	 with	 both	 found	 in	 high	 concentration	 from	 the	 effusions	 of	 some	
middle	ear	aspirates30.	Also,	Helicobacter	pylori	DNA,	derived	from	bacteria	exclusive	to	the	stomach	
and	duodenum,	has	been	reported	to	be	found	in	6-18%	of	middle	ear	effusions	using	polymerase	









A	number	of	environmental	 factors	have	been	 implicated	 in	 increasing	the	risk	of	otitis	media	and	
otitis	 media	 with	 effusion.	Many	 of	 these	 factors	 do	 not	 exclusively	 impact	 otitis	 media,	 but	 are	
general	 public	 health	 issues,	 and	 as	 such	 have	 been	 the	 subject	 of	 interest	 to	 policy	makers	 and	
public	 health	 advocates.	 Examples	of	 this	 include	 advocating	 for	 breastfeeding33	 and	 reduction	of	
tobacco	smoking	and	childhood	exposure34,35.	
1.1.2.2.1 Bacterial	and	Viral	Infection	
The	 bacterial	 microbiology	 of	 OME	 will	 be	 discussed	 in	 depth	 in	 section	 1.2;	 however,	 bacterial	
infection	has	been	 implicated	 to	play	a	key	 role	 in	 the	aetiology	of	OM	and	OME.	As	an	example,	
there	is	a	seasonal	variation	in	the	incidence	of	OME,	with	this	winter	preponderance	attributed	to	
the	increased	exposure	to	upper	respiratory	tract	infections	in	this	period36.	
The	 bacterium	 most	 frequently	 identified	 in	 patients	 with	 AOM	 is	 Streptococcus	 pneumoniae	 (S.	
pneumoniae),	 followed	 closely	 by	 nontypeable	 Haemophilus	 influenzae	 (NTHi)	 and	 Moraxella	
catarrhalis	 (M.	 catarrhalis).	 S.	 pneumoniae	 is	 identified	 in	 27.8%	 of	 AOM	 cases,	 Haemophilus	
influenzae	(H.	 influenzae)	 in	23.1%	and	M.	catarrhalis	 in	7.0%.	In	contrast,	NTHi	 is	more	commonly	
identified	 in	 patients	with	 recurrent	AOM	and	AOM	with	 tympanic	membrane	perforation	 (22.8%	
NTHi	vs	18.6%	for	S.	pneumoniae	and	4.1%	M,	catarrhalis)	37.	In	the	setting	of	OME,	bacteria	are	less	
likely	 to	 be	 identified,	with	 approximately	 half	 the	 average	 frequency	 compared	 to	AOM.	Despite	
this,	 NTHi	 is	 still	 considered	 the	 most	 common	 pathogen	 identified	 (11.6%),	 followed	 by	 S.	







In	addition,	 viruses	are	also	a	 cause	of	acute	otitis	media	and	 subsequently	predispose	 to	OME39.	
Viral	infection	is	often	found	to	precede	bacterial	super-infection40,	but	can	also	be	the	sole	causative	
agent41.	The	 rates	of	 co-infections	have	varied	between	5	 to	66%42.	 In	 co-infection,	 influenzae	A	has	
been	 shown	 to	 promote	 nasopharyngeal	 colonisation	 and	 dissemination	 of	 S.	 pneumoniae43.	









ear	 owing	 to	 the	 pressure	 differential.	 After	 seeding	 the	 middle	 ear,	 bacterial	 replication	 and	
infection	may	subsequently	result48,49.	
1.1.2.2.2 Allergy	
Infants	with	allergy	have	a	2-4.5-fold	 increased	 risk	of	 incidence	of	OME	compared	 to	non-allergic	
people50,51.	Specifically,	allergic	rhinitis	 (AR)	has	been	 implicated	 in	the	development	of	OME,	yet,	
this	association	is	still	under	debate.	One	cohort	study	from	birth	by	Kreiner-Moller	et	al.52	showed	
an	association	between	OME	and	AR	with	an	odds	ratio	of	3.36.	In	addition,	patients	with	AR	have	






A	 likely	 mechanism	 of	 OME	 in	 patients	 with	 AR	 is	 that	 allergic	 inflammation	 of	 the	 respiratory	
epithelium	that	 lines	the	ET	and	middle	ear,	resulting	 in	mucosal	swelling,	ET	dysfunction,	reduced	
mucociliary	 efficacy	 and	 delayed	 middle	 ear	 fluid	 clearance55,56.	 However,	 as	 suggested	 by	 the	
unified	upper	airway	concept,	there	is	evidence	that	the	middle	ear	mucosa	itself	also	contributes	to	





























In	 addition,	 in	 laboratory	 conditions,	 buccal	 epithelial	 cells	 exposed	 to	 cigarette	 smoke	 showed	
greater	 adherence	 of	 bacteria,	 including	 Pneumococci,	 Haemophilus	 strains,	 and	 Moraxella69.	









head	 position	 during	 feeds,	 improves	 nutrition,	 exposes	 infants	 to	 different	 microorganisms,	
and	has	antibacterial	and	immunological	benefits74.		














Sleeping	 prone	 results	 in	 decreased	 swallowing	 compared	 to	 a	 supine	 sleeping	 position80.	 This	
subsequently	impacts	upon	the	carriage	of	bacteria	in	the	upper	airways.	 	 Infants	who	sleep	prone	




ear	 disease	 in	 urban,	 rural	 and	 remote	 locations.	 The	 World	 Health	 Organisation	 regards	 a	
prevalence	of	chronic	OM	above	4	%	as	an	emergency,	yet,	conservative	estimates	of	chronic	otitis	
media	in	some	aboriginal	communities	have	been	estimated	to	be	above	10%82.	Among	Aboriginal	
Australians,	 OM	 develops	 at	 a	 younger	 age	 with	 the	 prevalence	 of	 OM	 and	 its	 associated	
complications	 higher	 than	 in	 non-Aboriginal	 children83.	 It	 has	 been	 reported	 that	 up	 to	 73%	 of	
indigenous	 children	 will	 have	 suffered	 otitis	 media	 in	 the	 first	 year	 of	 life	 and	 within	 some	
indigenous	communities	 the	prevalence	of	otitis	media	with	effusion	 is	50%84.	 In	a	cross-sectional	
study	 by	 Morris	 et	 al.82	 they	 found	 that	 in	 their	 examination	 of	 698	 children	 from	 aboriginal	
communities,	 91%	 had	 otitis	media,	 with	 80%	 of	 these	 children	 suffering	 bilateral	 ear	 disease.	 In	





perforation	 than	non-aboriginal	children85	 (up	 to	50%86).	 It	has	been	reported	 that	by	14	years	of	
age,	 these	 children	 will	 have	 suffered	 8	 times	 the	 amount	 of	 time	 with	 disease	 than	 their	 non-
aboriginal	counterparts	(24	months	vs	3	months)87.	This	discrepancy,	perhaps	unsurprisingly,	is	also	
mirrored	 by	 the	 length	 of	 time	 that	 indigenous	 children	 experience	 hearing	 loss	 (32	 months	 on	
average	versus	3	months	in	non-indigenous	children)2.		
It	is	thought	that	the	increased	occurrence	of	OM	is	in	part	due	to	the	higher	carriage	of	pathogenic	
bacteria	 in	 their	 upper	 airway	 and	 early	 colonisation	 in	 Aboriginal	 children.	 83,88.	Watson	 et	 al.88	
reported	 that	overall	 carriage	 rates	of	 the	major	middle	ear	pathogens	 in	 Indigenous	 children	<	2	
years	were	49%	for	S.	pneumoniae,	50%	for	M.	catarrhalis	and	41%	for	H.	influenzae.	In	comparison,	
for	non-Indigenous	children	from	the	same	area,	the	carriage	rates	were	25%	and	11%	respectively.	
Furthermore,	 carriage	of	more	 than	one	pathogen	has	 been	 associated	with	 a	 greater	 risk	 of	OM	
when	compared	to	the	carriage	of	a	single	pathogen	(33-fold	increase)83.	







and	 language	development	 can	potentially	be	 impacted,	especially	 in	 cases	of	bilateral	OME,	with	










pneumatic	 otoscopy	 is	 the	most	 robust	means	 for	 diagnosis,	 which	 combines	 visualisation	 of	 the	
tympanic	membrane	and	assessment	of	 its	mobility	and	has	a	 sensitivity	of	94%	and	 specificity	of	
80%	in	diagnosing	OME94.		
In	 addition,	 tympanometry	 is	 a	 frequently	 used	 as	 an	 adjunct	 for	 diagnosis,	 which	 provides	 a	
quantitative	measure	of	tympanic	membrane	mobility	and	middle	ear	function.	Tympanometry	has	a	
similar	sensitivity	(94%)	to	pneumatic	otoscopy,	but	a	lower	specificity	(64%)94.	
The	hearing	 loss	associated	with	OME	ranges	 from	normal	hearing	 to	moderate	hearing	 loss	 (0-55	
dB)95	and	is	a	reflection	of	the	volume,	but	not	viscosity,	of	the	effusion96.	Most	children	with	OME	
demonstrate	mild	hearing	 impairment,	with	mean	three-frequency	pure-tone	average	hearing	 loss	
of	 25	dB,	while	 a	 lesser	 proportion	 (approximately	 20%)	 exceed	35-dB	hearing	 loss97.	 In	 addition,	
there	 is	a	poor	correlation	with	parental	 reporting	of	hearing	 loss	and	 the	presence	or	absence	of	
OME98,99,	therefore	formal	audiological	assessment	is	essential.	
1.1.4 Management	of	otitis	media	with	effusion	
All	 patients	 presenting	with	OME	 should	 undergo	 age-appropriate	 assessment	 of	 their	 hearing	 to	
establish	 a	 baseline.	 For	 the	 youngest	 patients,	 aged	 8	 months	 to	 2.5	 years,	 visual	 response	
audiometry	 is	 typically	 used	 to	 assess	 hearing,	 which	 when	 performed	 by	 audiologists	 has	 been	
shown	to	provide	reliable	results	in	infants	as	young	as	6	months	100.	In	children,	aged	2.5	to	4,	play	





container)	 in	 response	 to	 a	 stimulus	 tone92.	 For	 children	 greater	 than	 4	 years	 of	 age,	 a	 formal	





from	 the	 date	 of	 diagnosis	 (if	 date	 of	 onset	 unknown),	 unless	 they	 are	 at	 high	 risk	 of	 speech,	
language	 or	 learning	 problems	 (e.g.	 children	 with	 severe	 vision	 impairment,	 craniofacial	
abnormalities	or	other	factors	impacting	cognitive	and	linguistic	development)	92.	The	reason	for	this	





criteria	 (type	 B	 to	 type	 A/C1,	 peak	 pressure	 >	 -200mm	 water)102.	 In	 addition,	 for	 children	 with	
bilateral	 OME	 of	 3	 months'	 duration	 or	 longer,	 only	 30%	 will	 resolve	 spontaneously	 by	 6	 to	 12	
months102.	 Therefore,	 decisions	 to	 commence	 therapy	 for	 OME	 is	 appropriate	 only	 if	 significant	
benefits	can	be	achieved	beyond	that	of	waiting	for	spontaneous	resolution.	
During	the	period	of	watchful	waiting,	strategies	for	improving	hearing	should	be	put	in	place	such	








for	 complete	 resolution	 of	 the	 effusion.	 However,	 antibiotic	 use	 was	 associated	 with	 a	 greater	
incidence	of	side	effects	such	as	experiencing	diarrhoea,	vomiting	or	skin	rash	and	did	not	improve	
hearing	loss	nor	rates	of	ventilation	tube	insertions.	As	a	result,	the	authors	concluded	that	the	small	
benefits	 of	 early	 OME	 resolution	 did	 not	 outweigh	 the	 potential	 risks	 of	 accelerating	 bacterial	
resistance.	
Similarly,	studies	looking	at	antibiotic	prophylaxis	to	prevent	OME	following	AOM	have	shown	only	a	
marginal	 improvement	 (4%)	 compared	 to	 no	 treatment	 for	 children	 at	 low	 risk.	 In	 contrast,	 for	
children	 at	 high	 risk,	 such	 as	 Indigenous	 children,	 prophylactic	 antibiotics	 significantly	 reduce	 the	
risks	of	tympanic	perforation	(14%),	showing	increased	return	of	normal	middle	ear	function	(9.6%)	
and	reduced	pneumococcal	carriage	(12%)83.	Again,	the	benefits	of	prophylaxis	may	be	outweighed	





the	 literature,	 Berkman	et	 al.104	 found	 that	 oral	 steroids	 did	 not	 have	 a	 significant	 impact	 on	 the	
resolution	of	effusion,	nor	in	the	hearing	levels	of	children	with	OME.		
Topical	intranasal	corticosteroids	are	associated	with	fewer	side	effects	than	oral	steroids,	however,	
again	 evidence	 of	 its	 efficacy	 is	 limited	 and	may	 depend	 on	 co-morbid	 factors.	 For	 example,	 in	 a	
double-blinded	 placebo	 controlled	 trial	 of	 children	 aged	 4	 to	 11	 years,	 no	 difference	 was	
demonstrated	in	the	resolution	of	effusion,	or	hearing	loss,	over	3	months	between	children	treated	















OME.	 Techniques	 include	 myringotomy	 without	 and	 without	 ventilation	 (tympanostomy)	 tube	




efficacy	 of	 ventilation	 tube	 insertion	 compared	 with	 conservative	 clinical	 observation	 was	
investigated.	 The	 insertion	of	 ventilation	 tubes	 reduced	 the	duration	of	 tympanic	effusion	by	32%	












insertion	 on	 language	 development	 remains	 inconclusive.	 There	 are	 a	 number	 of	 trials	 that	 have	
shown	 no	 improvement	 in	 language	 development	 between	 surgical	 and	 conservative	
therapies104,107.	 Yet,	 in	a	 randomised	control	 trial,	Maw	et	al.109	 found	 that	 tympanostomy	 tubes	




















not	 recommended	 unless	 there	 is	 a	 clear	 indication	 (for	 example,	 nasal	 obstruction	 or	 chronic	
adenoiditis)	 that	 exists	 other	 than	 OME92.	 The	 rationale	 behind	 this	 is	 that	 the	 surgical	 risks	 of	
adenoidectomy	do	not	 outweigh	 the	 limited,	 short	 term	benefit	 in	 children	 aged	3	 years	 or	 older	
without	prior	ventilation	tube	 insertion113.	These	risks	 (for	children	of	any	age)	 include:	prolonged	
anaesthetic	 time	 and	 intervention	 (i.e.	 intubation,	 intravenous	 fluids),	 a	 small	 potential	 for	
haemorrhage	 from	 the	 nasopharynx,	 and	 a	 longer	 recovery	 period	 (24	 to	 48	 hours).	 In	 addition,	
velopharyngeal	insufficiency	can	result	after	adenoidectomy,	though	only	rarely.		
In	 children	 older	 than	 4	 years	 of	 age,	 there	 is	 evidence	 that	 adenoidectomy	 at	 the	 time	 of	 initial	
ventilation	 tube	 insertion	 can	 be	 beneficial,	 especially	 for	 those	with	 adenoid	 tissue	 abutting	 the	
opening	 of	 the	 ET	 and	 torus	 tuaris114.	 Boonacker	 et	 al.115	 found	 that	 children	 undergoing	 both	
techniques	as	primary	therapy:	spent	50	fewer	days	with	OME	in	the	following	12	months,	had	lower	
failure	rates	(51%	vs	70%	without	adenoidectomy),	and	a	lower	rate	of	future	surgery	(2%	vs	19%).	
Similarly,	 in	 a	 review	 of	 literature	 by	Mikkals	 and	 Brigger116,	 adenoidectomy	 reduced	 the	 rate	 of	
repeat	tympanostomy	tube	insertion	for	children	under	the	age	of	four	only	(from	36%	to	17%),	with	
no	significant	effect	for	younger	children.	
In	 addition,	 there	 is	 evidence	 that	 adenoidectomy	 and	 myringotomy	 only	 (without	 insertion	 of	
ventilation	 tubes),	 has	 outcomes	 comparable	 to	 ventilation	 tube	 insertion,	with	 less	 otorrhea	 and	
tympanic	 membrane	 sequelae108.	 However,	 as	 discussed	 above,	 adenoidectomy	 has	 inherent	
complications	that	need	to	be	considered.	
1.1.4.6 Vaccination	
OM	 and	 OME	 is	 a	 polymicrobial	 disease,	 with	 four	 pathogens	 predominating:	 S.	 pneumoniae,	M.	





produce	vaccines	 to	 target	 these	pathogens.	Currently,	 there	are	only	vaccines	available	against	S.	
pneumoniae	and	H.	influenzae	type	B	(HiB).	




memory	 response.	 In	 contrast,	 whilst	 containing	 more	 serotypes,	 the	 23	 valent	 PPC	 is	 poorly	
immunogenic	 for	most	 serotypes	 in	 infants	 (children	aged	<2	years)	 and	does	not	 induce	 immune	
memory.	 Therefore,	 the	 13	 valent	 pneumococcal	 conjugate	 vaccine	 (PCV13)	 is	 recommended	 for	
infants	at	2,	4,	and	6	months	117.		
The	first	pneumococcal	conjugate	vaccine	was	introduced	in	Australia	in	2002	as	a	heptavalent	(PCV	
7)	 vaccine,	 later	 being	 replaced	by	 the	PCV	13	 in	 2011.	 The	PCV7	 contains	 polysaccharides	 of	 the	
capsular	 antigens	 for	 pneumococcal	 serotypes	 4,	 6B,	 9V,	 14,	 18C,	 19F,	 and	 23F.	 Since	 its	
introduction,	two	higher-valent	pneumococcal	conjugate	vaccines	have	become	widely	available,	the	
PCV	10	and	the	PCV	13.	These	two	vaccines	differ	from	each	other	in	the	number	of	serotypes	and	
carrier	 proteins	 used	 for	 their	 conjugation.	 PCV10,	 in	 addition	 to	 the	 serotypes	 present	 in	 PCV7,	
extended	the	vaccination	cover	to	serotypes	1,	5,	and	7F,	with	the	PCV	13	further	broadening	this	
coverage	to	include	serotypes	3,	6A	and	19A118.		
The	 majority	 of	 the	 literature	 has	 focused	 on	 the	 effect	 of	 the	 introduction	 of	 the	 PCV7	 on	 the	
incidence	of	AOM,	with	research	still	accumulating	on	the	impact	of	the	higher	valent	vaccines119.	In	








incidence	 following	 PCV7	 administration,	 due	 to	 replacement	 pneumococcal	 strains	 expressing	
serotypes	not	 contained	 in	PCV7,	 in	particular,	 phenotype	19A	119.	 In	 addition,	 the	pneumococcal	
conjugate	 vaccines	 were	 not	 found	 to	 be	 effective	 if	 administered	 after	 the	 development	 of	
recurrent	otitis	media119,124.		
In	the	Australian	Aboriginal	population,	the	introduction	of	the	PCV	7	and	10	have	shown	to	impact	
the	 bacterial	 aetiology	 of	 OM.	 The	 dissemination	 of	 the	 PCV	 7	 reduced	 vaccine-serotype	 invasive	
pneumococcal	disease	significantly	(74%	decrease	in	both	indigenous	and	non-indigenous	Australian	
125)	 and	has	had	 indirect	protective	effects	by	 reducing	 the	 carriage	of	pathogenic	bacteria	 in	 the	
upper	 airway126.	 At	 the	 introduction	 of	 the	 PCV	 10,	 rates	 of	 suppurative	 otitis	 media	 further	
decreased	by	12%.	However,	ongoing	surveillance	showed	a	reciprocal	increase	in	the	rates	of	OME	
(10%)	 and	 the	 emergence	 of	 increased	 incidence	 of	 non-PCV	 serotype	 invasive	 pneumococcal	
disease	125.	
Since	 the	 widespread	 dissemination	 of	 the	 PCV,	 non-typeable	 (non-encapsulated)	 Haemophilus	
influenzae	(NTHi)	has	become	the	most	common	cause	of	otitis	media127,128.	Unfortunately,	there	is	
currently	 no	 effective	 vaccine	 to	 combat	 this	 group	 of	 bacteria.	 While	 vaccines	 against	 type	 B	
(encapsulated)	 Haemophilus	 influenzae	 (HiB)	 have	 been	 effective	 in	 eliminating	 infection	 by	 this	
encapsulated	 strain,	 these	 conjugate	 vaccines	 show	 no	 effect	 against	 NTHi.	 There	 is	 ongoing	








administration	 is	 recommended	for	all	children	greater	 than	6	months.	Whilst	 Influenza	virus	does	
not	have	as	strong	an	association	with	OM	as	other	respiratory	viruses	such	as	respiratory	syncytial	
virus,	 parainfluenza	 and	 human	 metapneumovirus,	 there	 is	 evidence	 that	 influenza	 vaccine	
administration	 reduces	 the	 rates	 of	 AOM,	 though	 only	 modestly.	 In	 a	 2015	meta-analysis	 of	 five	
randomised	 trials	 by	 Norhayati	 and	 Azman,	 which	 included	 4736	 children	 aged	 six	months	 to	 six	
years,	 influenza	 vaccine	 administration	 reduced	 the	 risk	 of	 at	 least	 one	 episode	 of	 AOM	 over	 six	
months	of	follow-up	by	4%.	The	authors	also	noted	a	decrease	in	antibiotic	prescribing	for	AOM	by	







OM	 is	 a	 multi-factorial	 disease,	 with	 many	 associated	 risk	 factors,	 both	 host	 and	 environmental.	
Despite	this	complexity,	bacterial	pathogens	have	been	strongly	associated	with	OM	development.	
In	 the	 past,	 identification	 of	 bacteria	 was	 limited	 due	 to	 the	 restraints	 inherent	 with	 traditional	
culture	 techniques,	 however,	 with	 advancements	 in	 culture-independent	 techniques	 such	 as	
polymerase	chain	 reaction	and	16S	 rRNA	pyrosequencing,	bacteria	are	almost	universally	 found	 in	
aspirates	 of	 the	 middle	 ear.	 The	 following	 section	 discusses	 some	 of	 the	 recent	 advances	 in	 the	
detection	of	bacteria	and	summarises	the	role	of	bacteria	in	OM,	with	a	focus	on	OME.	
1.2.1 Detection	of	bacteria	and	its	advances	
Only	 three	 decades	 ago,	 OME	was	 assumed	 to	 be	 a	 sterile	 condition	 that	was	mainly	 due	 to	 the	
obstruction	of	 the	Eustachian	 tube.	However,	with	 conventional	 culture	methods,	 bacteria	 can	be	
identified	 in	 40%	 of	 cases	 of	 OME38,	 with	 those	 results	 forming	 the	 foundation	 for	 our	 classical	
understanding	 of	 the	 bacteria	 associated	 with	 OM	 and	 OME.	 However,	 culture-dependent	
techniques	are	inherently	limited.	They	rely	on	bacterial	growth,	and	it	is	difficult	to	use	traditional	
culture	 methods	 to	 isolate	 more	 than	 fraction	 of	 micro-organisms	 known	 to	 be	 present	 in	 any	
environment130.	 In	 addition,	 isolation	of	 bacteria	 has	 an	 inherent	 selection	 bias,	 due	 to	 the	often	
specific	 and	 fastidious	 nature	 of	 bacteria	 and	 their	 growth	 requirements	 (growth	 media,	
atmospheric	conditions,	temperature	etc.).		
During	the	past	two	decades,	there	has	been	a	shift	towards	the	identification	of	bacteria	that	does	
not	 require	 bacteria	 to	 be	 grown	 in	media.	 Conventional	 culture-independent	 techniques	 such	 as	







organisms,	 leading	 to	 a	 wider	 spectrum	 of	 organisms	 involved	 in	 OM	 to	 be	 described.	 With	 the	
identification	 of	 these	 new	 bacterial	 species,	 there	 has	 been	 a	 greater	 appreciation	 for	 the	
complexity	of	the	bacterial	interactions	within	the	middle	ear.	However,	whilst	these	techniques	do	
not	 rely	on	culture	 to	 identify	microbes,	 an	 inherent	 selection	bias	 remains,	as	utilisation	of	 these	
technologies	 requires	 the	 investigator	 to	 first	 target	 the	bacteria	 they	wish	 to	 investigate	 prior	 to	
identifying	the	organism.		
Recently,	 culture-independent	molecular	methods	 involving	 the	 use	 of	 16S	 rRNA	 sequences	 have	
allowed	non-selective	species	 identification	by	means	of	phylogenetic	sequence	analysis.	16S	rRNA	
sequencing	 was	 the	 first	 molecular-based	 technology	 to	 be	 generally	 applied	 to	 the	 human	
microbiota.	 It	 provides	 a	 non-targeted,	 quantitative	 description	 of	 the	 bacteria	 present	 from	 a	




11	 Australian	 Aboriginal	 Children.	 The	 following	 section	 will	 provide	 an	 overview	 of	 16S	 rRNA	
sequencing	 technology	 and	 discuss	 some	 of	 the	 potential	 applications	 of	 this	 technology	 in	 the	
context	of	otitis	media.	
1.2.1.1 Culture-independent	bacterial	identification	and	16S	rRNA	gene	sequencing	
The	 development	 of	 PCR	 as	 a	 technology	 has	 been	 one	 of	 the	 cornerstones	 of	 conventional	
molecular	science	and	biomedical	research.	Once	DNA	is	extracted	from	a	sample,	PCR	allows	for	the	
amplification	 of	 specific	 regions	 of	 DNA	 more	 than	 a	 billion-fold,	 by	 utilising	 the	 enzyme	 DNA	






including	 in	 the	 sequencing	 of	 the	 human	 genome134,	 and	 is	 the	 foundation	 by	 which	 16S	 rRNA	
sequencing	is	possible.		
In	 the	 setting	of	OM,	 it	had	previously	been	unknown	whether	a	PCR	product	 from	bacterial	DNA	
collected	 from	MEF	 represented	viable	organisms	or	not.	However,	Rayner	et	al.135	demonstrated	






























These	 OTUs	 are	 then	 compared	 to	 reference	 databases	 based	 on	 similarity	 for	 taxonomic	
assignment.	 A	 level	 of	 97%	 similarity	 of	 the	 sequence	 identity	 is	 often	 chosen	 as	 being	
representative	of	a	species	and	95%	for	a	genus	when	using	partial	16rRNA	gene	sequences130.	The	
accuracy	 of	 identification	 is	 dependent	 on	 the	 reference	 database	 that	 is	 chosen.	 Examples	 of	
available	 libraries	 include:	 Greengenes139,	 SILVA140	 and	 The	 Ribosomal	 Database	 Project141.	
However,	these	databases	themselves	contain	erroneous	16S	rRNA	sequences142,	which	can	lead	to	








16S	 rRNA	gene	 sequencing	allows	 for	 several	descriptive	assessments	of	a	 taxonomic	 composition	
and	 phylogenetic	 diversity	 of	 a	microbiome.	Once	 a	microbiome	 sequence	 is	 obtained,	 and	OTUs	
defined,	 the	 community	 characteristics	 of	 the	 microbiome	 are	 described	 by	 their	 characteristic	
parameters.	Descriptions	of	these	parameters	 include	community	richness,	which	is	the	number	of	
unique	 taxonomic	 units	 detected	 in	 a	 sample,	 and	 evenness,	 which	 is	 the	 relative	 number	 of	
taxonomic	units	 in	a	 sample	 (figure	1-2).	 Furthermore,	 reporting	diversity,	 such	as	alpha	and	beta	
diversities,	 are	 valuable	 descriptors	 of	 the	 community.	 Alpha	 diversity	 (e.g.	 Shannon	 Diversity	
Index146),	is	a	measure	of	the	richness	and	evenness	within	a	sample,	whilst	beta	diversity	(e.g.	Bray-
Curtis147	or	UniFrac148)	represents	the	similarity	of	the	bacterial	composition	between	samples.	
By	 comparing	 sequences	 of	 the	 16S	 rRNA	 gene	 in	 clinical	 samples	 to	 pre-curated	 databases	
containing	known	16S	 rRNA	sequences,	 this	 technology	allows	 for	a	non-targeted	approach	 to	 the	








Figure	 1-2	 Descriptions	 of	 microbiome	 data.	 A	 diagram	 demonstrating	 species	 richness	 and	






environmental	 interactions	 living	 on	 and	 in	 an	 individual.	 The	 micro-organisms	 making	 up	 the	
microbiome	 are	 themselves	 referred	 to	 as	 the	microbiota	 (microbial	 community)	 and	 can	 include	










The	 bacterial	microbiome	 has	 been	 characterised	 at	many	 body	 sites.	 The	microbial	 communities	
have	 been	 shown	 to	 contribute	 essential	 functionalities	 to	 human	 physiology	 and	 are	 considered	
essential	for	the	maintenance	of	human	health149.	For	instance,	in	the	gastrointestinal	tract,	the	gut	
microbiome	has	been	 implicated	 in	 the	development	of	 the	 immune	 system,	promoting	 intestinal	
angiogenesis	 and	 assisting	 in	 digestion150,151.	 In	 health,	 the	 commensal	 bacteria	 maintain	
homeostasis	 and	 also	 exert	 a	 biological	 pressure	 to	 inhibit	 colonisation	 by	 pathogens,	 in	 a	
phenomenon	referred	to	as	colonisation	resistance152.	
However,	 it	 has	 been	 consistently	 shown	 that	 there	 is	 also	 high	 interpersonal	 variability	within	 a	
cohort	of	healthy	individuals153,154.	Within	these	populations,	some	body	sites	show	a	more	stable	








example,	 Segata	 et	 al.157	 sampled	 the	 oral	 cavity	 at	 seven	 different	 sites	 within	 the	 mouth	 (the	
buccal	mucosa,	hard	palate,	 gingivae,	 tongue,	 saliva,	 and	 supra-	 and	 sub-gingival	plaque)	and	also	
the	throat	and	tonsils.	They	analysed	their	samples	with	16S	rRNA	techniques	and	found	that	three	
distinct	 bacterial	 communities	 existed	 within	 these	 sites;	 the	 buccal	 mucosa,	 gingivae	 and	 hard	
palate	had	similar	microbiota,	while	the	saliva,	tongue,	tonsils	and	throat,	and	the	supra-	and	sub-







several	 genera	 predominate	 a	 body	 site,	 but	 are	 accompanied	 by	 a	 long	 tail	 list	 of	 less	 abundant	
organisms.		
While	the	microbiota	in	health	has	been	reported	to	have	a	high	degree	of	richness	and	variability,	in	
a	 disease	 state,	 often	 the	 converse	 is	 true.	 During	 times	 of	 disease,	 one	 bacteria	 (considered	 the	
etiological	 pathogen)	 emerges	 as	 the	 dominant	 strain	 either	 from	within	 the	 pool	 of	 commensal	
bacteria	or	exogeneously.	This	results	in	the	flattening	of	the	richness	of	the	microbiota	in	the	niche,	
representing	a	dysbiotic	microbiota.	For	example,	this	phenomenon	has	been	reported	in	a	number	
of	 studies	 looking	 at	 the	 microbiome	 of	 chronic	 rhinosinusitis.	 In	 these	 individuals	 with	 chronic	
disease,	 there	 is	 a	 dysbiotic	microbiome	 of	 the	 sinuses,	with	 the	 emergence	 of	 Staphylococcus	 in	









the	 gastrointestinal	 tract.	 C.	 difficile	 infection	 is	 brought	 about	 due	 to	 the	 extended	 use	 of	
antibiotics.	As	 a	 result,	 there	 is	 a	 decrease	 in	 richness	of	 the	microbiome	of	 the	 gut	 commensals,	











Up	 until	 2016,	 studies	 suggested	 that	 the	 healthy	 human	 middle	 ear	 and	 mastoid	 cavities	 were	





control	 patients	 (undergoing	 Cochlear	 implant	 or	 benign	 brain	 tumour	 removal),	 using	 16S	 rRNA	
techniques.	 The	 bacterial	 genera	 included	 Novosphingobium,	 Staphylococcus,	 Streptococcus,	
Escherichia-Shigella,	and	Burkholderia.	
There	 have	 been	 two	 studies	 that	 have	 utilised	 16S	 rRNA	 gene	 sequencing	 to	 characterise	 the	
microbiota	in	OME.	Liu	et	al.131	characterised	the	microbiota	present	in	one	patient	with	OME.	They	
found	 a	 high	 abundance	 of	 the	 bacterial	 family	 Pseudomonadaceae,	 which	 predominated	 the	
sample	 of	 MEF	 (82.7%).	 They	 also	 identified	 the	 families	 of	 common	 ear	 pathogens:	
Streptococcaceae,	 Pastuerellaceae	 (Haemophilus)	 and	 Moraxellaceae,	 however,	 genus	 level	
differentiation	 and	 relative	 abundance	 were	 not	 reported.	 Jervis	 Bardy	 et	 al.164	 reported	 on	 the	
microbiota	 of	 the	 middle	 ear	 in	 OME	 in	 an	 Australian	 Aboriginal	 cohort.	 They	 found	 that	 in	 11	













pneumoniae,	H.	 influenzae	and	M.	 catarrhalis	predominate	 the	microbiota	of	 the	middle	ear.	 In	 a	
review	of	the	literature,	from	1970	to	2014,	Ngo	et	al.37	analysed	the	data	from	66	articles	reporting	
on	the	microbiology	of	 the	middle	ear.	Of	 the	66	articles,	38	studies	 involved	sampling	the	middle	
ear	in	AOM.	The	authors	reported	that	despite	some	geographical	variation,	S.	pneumoniae	(29/38	
studies)	 was	 the	 most	 predominant	 bacterium,	 followed	 by	 H.	 influenzae	 (6/38).	 In	 addition,	
multispecies	 infection	 was	 common,	 with	 the	 frequency	 of	 polymicrobial	 detection	 high	 for	 S.	
pneumoniae	(27.8%,	range	9.9%-49.9%),	H.	influenzae	(23.1%,	range	5.0%-54.6%)	and	M.	catarrhalis	
(7%,	 range	 0.5%–27.8%).	 In	 contrast,	 in	 some	 regions	 (South	 America,	 Europe	 and	 Oceania)	 H.	
influenzae	 predominated	 in	 aspirates	 from	 recurrent	 AOM	 and	 those	 with	 AOM	 with	 treatment	
failure.	
In	cases	of	CSOM,	Staphylococcus	aureus	 (S.	aureus)	and	Pseudomonas	aeruginosa	 (P.	aeruginosa)	








and	 they	 also	 found	 variable	 abundances	 of	 Haemophilus,	 Staphylococcus,	 Alloiococcus,	 and	
Streptococcus	 from	 these	 patients.	 There	 was	 a	 lower	 abundance	 of	 Propionibacterium	 in	 CSOM	
patients	 than	 controls,	 suggesting	 a	 potential	 protective	 role.	 Additionally,	 Alloiococcus	 and	
Haemophilus	were	 detected	 commonly	 in	 CSOM	patients	with	 underlying	 cholesteatoma.	 Despite	
the	detection	of	these	extra	bacteria,	their	role	in	CSOM	remains	undetermined.	
1.2.3 The	nasopharynx	as	a	reservoir	for	otitis	media	
The	 nasopharynx	 is	 anatomically	 located	 at	 the	 confluence	 between	 the	 posterior	 nasal	 cavity,	
middle	 ear	 (via	 the	 ET)	 and	 the	 lower	 aerodigestive	 tract.	 As	 a	 result,	 it	 is	 an	 ecological	 niche	 for	
many	commensal	bacteria	and	potential	 respiratory	or	 invasive	pathogens.	During	times	of	health,	
there	 seems	 to	 be	 a	 complex	 symbiosis	 between	 the	 host,	 commensal	 bacteria	 and	 pathogenic	
bacteria,	 which	 maintains	 “health”.	 However,	 disturbance	 of	 a	 balanced	 nasopharyngeal	 (NP)	
microbiome	might	 be	 involved	 in	 the	 onset	 of	 symptomatic	 infections	with	 these	 pathogens.	 The	
exact	mechanisms	by	which	this	occurs	remain	largely	undetermined,	although	an	imbalance	in	the	
composition	 of	 the	 microbiota	 caused	 by,	 for	 example,	 the	 arrival	 of	 new	 pathogens,	 viral	 co-
infection	 or	 other	 factors,	 such	 as	 antibiotic	 use167	 and	 cigarette	 smoke	 exposure70,	 have	 been	
suggested.		
The	 nasopharyngeal	 microbiota	 develops	 from	 the	 first	 day	 of	 life	 and	 evolves	 throughout	 the	
human	 lifespan.	 Bosch	 et	 al.168	 followed	 102	 children	 longitudinally	 from	birth	 to	 six	months	 and	
periodically	 swabbed	the	nasopharynx.	They	 found	that	despite	 the	significant	difference	between	
individuals	 on	 nasopharyngeal	 microbiota	 carriage	 during	 the	 study,	 that	 there	 was	 an	 initial	
streptococcus	viridans-predomination	across	the	population	in	the	first	week.	Following	that,	infants	






al.169	 characterised	 the	microbiota	of	 the	nasopharynx	 in	healthy	 individuals	using	16S	 rRNA	gene	
sequencing.	 They	 described	 a	 core	microbiota	 that	was	 similar	 to	 Bosh	 et	 al,	 which	 consisted	 of:	
Moraxella	 (40%	relative	abundance),	Haemophilus	 (20%)	and	Streptococcus	 (12%),	Dolosigranulum	
(5%),	 and	Corynebacterium	 (2%).	 In	addition	 to	 the	above,	Bogaert	et	al.169	 also	 found	a	 seasonal	
difference	 of	 the	 nasopharyngeal	 microbiota	 that	 was	 independent	 of	 antibiotic	 use	 or	 viral	 co-
infection;	with	 an	 increase	 in	 abundance	 of	Proteobacteria,	 Fusobacteria,	 Cyanobacteria	with	 less	
Bacteriodetes	during	winter	months,	which	may	reflect	seasonal	changes	in	OM.	





of	 nasopharyngeal	 contents	 into	 the	 middle	 ear	 via	 the	 Eustachian	 tube.	 This	 mechanism	 is	
illustrated	 by	 the	 fact	 that	 pepsin,	 an	 enzyme	 resident	 within	 the	 stomach,	 and	 its	 precursor	
pepsinogen	have	been	demonstrated	within	middle	ear	fluid30,173.		
Two	 studies,	 utilising	 culture-independent	 techniques	 have	 compared	 the	 nasopharyngeal	
microbiota	 in	healthy	 children	and	 those	with	AOM.	 In	 their	 study	 involving	163	 infants	 (153	with	
AOM,	10	without)	with	sample	collection	over	6	years,	Hilty	et	al.174	found	that	control	patients	had	
a	richer	and	more	diverse	microbiota,	whereas	patients	with	AOM	showed	a	predominance	of	 the	
three	 classic	 otopathogens	 in	 their	 nasopharynx.	 Specifically,	 control	 patients	 harboured	 both	 a	
higher	 prevalence	 and	 relative	 abundance	 of	 Staphylococcaceae,	 Flavobacteriaceae,	
Carnobacteriaceae	and	Comamonadaceae.	Similarly,	Pettigrew	et	al.159,	 found	that	colonisation	of	






Dolosigranulum	 colonising	 the	 nasopharynx	 were	 less	 likely	 to	 have	 AOM.	 Additionally,	 patients	
treated	 with	 antibiotics	 in	 the	 preceding	 6	 months	 had	 a	 greater	 abundance	 of	 Lactococcus	 and	
Propionibacterium	 and	were	also	 less	 likely	 to	have	AOM.	The	authors	 suggest	 that	 these	bacteria	










external	ear	canal	 to	be	predominated	by	A.	otitidis	 (83%),	Corynebacteria	 spp.	 (otitidis	 (55%)	and	
auris	 (22%),	 but	 also	 a	 significant	 amount	 of	 Staphylococcus	 spp.	 (auricularis,	 epidermidis,	 capitis,	
intermedius,	66%	in	total).	Additionally,	P.	aeruginosa	has	also	been	suggested	as	a	coloniser	of	the	
external	 canal177,178.	 In	 contrast,	 during	 episodes	 of	 AOM,	 there	 seems	 to	 be	 a	 shift	 in	 the	
microbiota	 that	 is	 identified	 from	the	external	 canal.	Heslop	et	al.179,	 found	 that	 the	predominant	
bacteria	 were	 instead:	 P.	 aeruginosa	 (36%),	 S.	 pneumoniae	 (27%),	 S.	 aureus	 (18%)	 and	 beta	
hemolytic	group	A	Streptococcus	(18%).		
P.	aeruginosa	 and	S.	aureus	are	considered	 the	 two	most	 commonly	 identified	bacterial	 causes	of	



















canal	 to	colonise	 the	middle	ear	or	whether	 they	are	merely	contaminants	as	a	 result	of	 sampling	
bacteria	from	the	middle	ear.	There	is	clear	evidence	of	P.	aeruginosa	and	S.	aureus	infection	of	the	










A.	otitidis	 is	 a	 strictly	 aerobic,	 gram-positive	 cocci	 first	documented	 in	MEF	by	 Faden	and	Dryja	 in	
1989	188.	 It	 is	weakly	 catalase	positive	and	arranges	 in	pairs,	 small	 clusters	and	 tetrads.	A.	otitidis	
grows	slowly	with	small	alpha-haemolytic	colonies	when	incubated	on	blood	agar	after	3-4	days	of	






with	non-purulent	OME	 (19	 to	64%)	 (table	1-1)	 and	has	been	 identified	 from	MEF	 samples	as	 the	
single	dominant	bacterial	species195.	Moreover,	it	has	been	proposed	that	the	presence	of	A.	otitidis	
in	the	MEF	correlates	with	a	longer	duration	of	OME181.	




perforation	 occurs	 in	 40%	 of	 AOM,	 which	 may	 have	 allowed	 A.	 otitidis	 to	 translocate	 prior	 to	
sampling.	 This	 can	 be	 illustrated	 by	 the	 fact	 that	Marsh	 et	 al.183	 reported	 that	 37%	 of	 Australian	













































































Table	 1-3	 Studies	 reporting	 the	 incidence	 of	 A.	 otitidis	 from	 samples	 of	 the	 nasopharynx	 and	
external	auditory	canal	using	polymerase	chain	reaction	
A.	otitidis	is	commonly	considered	a	commensal	of	the	external	canal	and	has	been	identified	in	high	








However,	 the	potential	 for	pathogenicity	 for	A.	otitidis	has	been	documented;	A.	otitidis	has	been	
found	 to	 invade	 intracellularly188,	 to	 modulate	 immune	 responses	 in	 vitro211-216	 and	 has	 been	
implicated	in		cases	of	implant	infection217,218,	endocarditis219,	and	endopthalmitis	217.	In	addition,	
when	 A.	 otitidis	was	 introduced	 into	 the	 middle	 ear	 of	 rats,	 a	 serous	 OME	 developed,	 with	 the	








S.	 pneumoniae	 is	 a	 Gram-positive,	 alpha	 haemolytic	 coccus	 that	 is	 often	 found	 to	 colonise	 the	
nasopharynx.	 It	 is	a	fastidious	bacterium,	growing	best	 in	5	percent	carbon	dioxide,	and	requires	a	
source	of	catalase	(e.g.,	blood)	to	grow	on	agar	plates.	Virtually	all	strains	of	S.	pneumoniae	have	a	
polysaccharide	capsule,	which	is	the	basis	for	serotyping.	There	are	at	least	97	antigenically	distinct	
serotypes	 of	 encapsulated	S.	 pneumoniae	 222.	Of	 these	 serotypes,	 20	 account	 for	 80%	of	 invasive	
pneumococcal	disease223.	 The	dominant	 serotypes	associated	with	 invasive	pneumococcal	disease	
worldwide	include	1,	3,	4,	6A,	6B,	7F,	8,	9V,	14,	18C,	19F,	and	23F.	In	young	children,	6,	14,	18,	19,	
and	23F	predominate.	 The	 serotypes	most	 commonly	 associated	with	AOM	are	3,	 6A,	 6B,	 9V,	 14,	
19A,	19F,	and	23F,	with	serotypes	1,	5,	and	7F	rarely	associated	224.		
The	pathogenesis	of	S.	pneumoniae	stems	from	its	ability	to	colonise	the	nasopharynx.	The	rates	of	






age	 of	 10.	 The	 pneumococcal	 capsule	 not	 only	 plays	 a	 protective	 role	 against	 opsonisation	 and	
phagocytosis,	 but	 also	 promotes	 colonization	 of	 the	 nasopharynx	 by	 reducing	 mucosal	 clearance	
from	 the	nasopharynx225-227.	Once	 colonised	within	 the	nasopharynx,	S.	 pneumoniae	 can	migrate	
and	 cause	 a	 broad	 range	 of	 disease.	 The	 most	 common	 infections	 occur	 in	 the	 respiratory	 tract	
including:	 bronchitis,	 pneumonia	 and	 OM.	 S.	 pneumoniae	 can	 also	 invade	 and	 spread	 via	 the	
bloodstream,	 causing	bacteraemia	and	meningitis228.	Additionally,	 there	 is	 evidence	 that	 infection	
with	 influenza	A	virus	 induces	 commensal	S.	pneumoniae	 to	disseminate	beyond	 the	nasopharynx	
and	predisposes	to	S.	pneumoniae	AOM229.	In	AOM,	S.	pneumoniae	has	been	identified	in	30-40%	of	
cases,	 with	 evidence	 that	 the	 same	 bacteria	 can	 be	 found	 to	 colonize	 the	 nasopharynx37,230.	
However,	in	contrast,	S.	pneumoniae	has	also	been	portrayed	as	a	protective	commensal	bacterium.	
Once	 the	nasopharynx	 is	 colonised	S.	pneumoniae	 inhibits	 colonization	by	other	harmful	potential	
pathogens,	such	as	Streptococcus	pyogenes	and	Staphylococcus	aureus	by	“competitive	exclusion”,	




the	 rates	 of	 resistance	 has	 rapidly	 increased.	 Patterns	 of	 drug	 resistance	 and	 the	 prevalence	 of	
specific	clones	are	variable	among	different	regions/countries	and	evolve	over	time	and	often	reflect	
prescribing	practices	of	 that	 region.	Six	 serotypes	 (i.e.,	6A,	6B,	9V,	14,	19F,	23F)	account	 for	more	
than	80%	of	penicillin-resistant	or	macrolide-resistant	S.	pneumoniae	worldwide.	These	strains	are	








pneumoniae.	 Pankuch	 et	 al.234	 found	 that	 vancomycin,	 teicoplanin,	 linezolid	 and	
quinupristin/dalfopristin	 were	 100%	 effective	 in	 eradicating	 346	 S.	 pneumoniae	 strains	 tested.	 In	
addition,	 fluoroquinolones	 (levofloxacin,	 moxifloxacin,	 gatifloxacin)	 have	 also	 shown	 good	
microbiologic	 and	 clinical	 efficacy	 against	 penicillin-resistant	 pneumococci235.	 However,	 resistance	




H.	 influenzae	 is	 a	 gram	 positive,	 oxidase	 positive,	 facultatively	 anaerobic,	 and	 non-motile	
coccobacillus	 that	 is	 a	 commensal	 of	 the	 human	 pharynges.	 In	 clinical	 specimens	 obtained	 from	
patients	who	 have	 received	 β	 lactam	 antibiotics,	H.	 influenzae	 can	 instead	 appear	 as	 filamentous	
rods.	By	18	months	of	age,	one-third	of	children	have	had	H.	influenzae	nasopharyngeal	colonization	
with	 both	 typeable	 and	 non-typeable	H.	 influenzae	 (NTHi)	 236,237.	 The	 name	Haemophilus	 makes	
reference	to	the	organisms'	absolute	nutritional	requirement	for	haemin	(factor	X)	and	nicotinamide	
adenine	 dinucleotide	 (factor	 V)	 for	 growth.	H.	 influenzae	may	 be	 involved	 in	 a	 variety	 of	 invasive	
infections,	 mostly	 within	 the	 respiratory	 tract	 and	 is	 commonly	 associated	 with	 pneumonia,	
bronchitis,	epiglottitis,	sinusitis	and	otitis	media.	Outside	of	the	respiratory	tract,	H.	 influenzae	has	
been	implicated	in	bacteraemia,	cellulitis,	septic	arthritis	and	meningitis.	As	discussed,	H.	influenzae	









H.	 influenzae	 is	 categorised	 into	 encapsulated	 or	 non-encapsulated	 (non-typeable)	 strains.	 For	
encapsulated	 (typeable)	 strains,	 there	 are	 six	 serologically	 distinct	 surface	 capsules	 that	 are	
designated	serotypes	a-f	(based	on	agglutination	of	rabbit	sera),	whilst	non-typeable	strains	do	not	
agglutinate	 with	 a-f	 typing	 sera.	 The	 polysaccharide	 capsules	 of	 encapsulated	 H.	 influenzae	 are	
strongly	 negatively	 charged,	 which	 facilitates	 resistance	 of	 the	 bacteria	 to	 opsonisation	 and	
neutrophil	phagocytosis240.	Additionally,	they	are	the	most	important	virulence	factors	for	invasive	
infections,	 for	 example,	 HiB	 strains	 are	 considered	 more	 pathogenic	 than	 the	 other	 five	
serotypes241,	 with	 2-10%	 of	H.	 influenzae	 infections	 attributed	 to	 this	 type.	 Fortunately,	with	 the	
advent	and	widespread	use	of	the	HIB	vaccine,	these	rates	have	dramatically	dropped242.	
Non-typeable	H.	 influenzae	(NTHi)	on	the	other	hand	 is	non-encapsulated.	Whilst	the	absence	of	a	
polysaccharide	 capsule	 contributes	 to	 the	 susceptibility	 of	 NTHi	 to	 complement-mediated	
bacteriolysis	and	phagocytosis,	NTHi	is	responsible	for	the	majority	of	H.	influenzae	associated	OM.	
Differentiation	of	NTHi	from	capsule-producing	H.	influenzae	depends	on	failure	to	detect	a	capsule.	
Traditionally,	 this	 is	 established	by	demonstrating	 agglutination	of	 the	bacteria	 in	 the	presence	of	
capsule	 specific	 types	 a-f	 antisera.	However,	 the	 ability	 to	detect	 the	 genes	bexA	 and	bexB	 in	 the	
capsule-region	by	PCR	have	been	suggested	to	be	more	reliable,	with	false	negative/positive	rates	of	
serotyping	 in	 the	 region	 of	 40%243.	 With	 the	 advent	 of	 HIB	 vaccines	 and	 increasing	 survival	 of	
individuals	 with	 medical	 co-morbidities,	 invasive	 infections	 with	 NTHi	 are	 now	 more	 widespread	
among	all	age	groups	than	those	caused	by	encapsulated	strains,	with	NTHi	pharyngeal	colonisation	
















amoxicillin.	 In	 addition,	 H.	 influenzae	 has	 low	 susceptibility	 to	 macrolide	 antibiotics	 due	 to	 an	
membrane	bound	efflux	pumps	 that	 are	 able	 to	neutralise	 this	 class	of	 antibiotics247.	However	of	
this	 class,	 azithromycin	 is	more	 active	 in	 vitro	 against	most	 strains	 of	H.	 influenzae	 and	 has	more	
rapid	killing	and	a	longer	post-antibiotic	effect	than	clarithromycin248.	
Some	H.	 influenzae	 strains	 that	don't	express	β-lactamase	are,	nevertheless,	 resistant	 to	ampicillin	
and	 amoxicillin.	 These	 strains	 are	 designated	 β-lactamase	 negative,	 ampicillin	 resistance	 (BLNAR)	
strains	 and	 gain	 their	 resistance	 due	 to	 characteristic	 ftsl	 gene	mutations,	which	 result	 in	 altered	
penicillin-binding	 protein	 3	 structure.	 BLNAR	 contribute	 up	 to	 31%	 of	 resistant	 strains	 and	 are	
identified	 by	 having	 an	 MIC	 ≥	4	mg/L	 to	 ampicillin	 and	 a	 negative	 test	 for	 β-lactamase	 249.	 In	
addition,	 there	 are	 H.	 influenzae	 strains	 that	 are	 known	 as	 β-lactamase	 positive,	 ampicillin	 and	
ampicillin/clavulanate	 resistant	 (BLPACR)	 strains.	 These	 strains	 both	 produce	 β-lactamase	 and	





ampicillin	MICs	 ≥4	mg/L	 and	 co-amoxyclav	MICs	of	 ≥8	mg/L.	 BLPACR	 strains	 are	 less	 common	and	
clinically	are	still	susceptible	to	ampicillin/clavulanate250.	
Despite	the	existence	of	BLNAR	and	BLPACR	stains,	generally	speaking,	drugs	that	achieve	high	rates	
of	eradication	of	H.	 influenzae	 include	drug	combinations	of	penicillins	with	β	 lactamase	 inhibitors	
(co-amoxyclavulanate)	 and	 extended-spectrum	 penicillin	 drugs	 (Piperacillin).	 Additionally,	 second	
and	third	generation	cephalosporins	and	carbapenems	are	stable	to	β	lactamase	and	are	therefore	




M.	 catarrhalis	 is	 a	 large	 Gram-negative	 coccobacillus	 that	 is	 exclusively	 present	 in	 humans.	M.	
catarrhalis	has	been	reclassified	in	the	last	40	years	and	has	previously	been	called	Mima	polymorha,	
Neisseria	 catarrhalis	 and	 Branhamella	 catarrhalis.	 Like	 S.	 pneumoniae	 and	 H.	 influenzae,	 M.	
catarrhalis	 had	 been	 considered	 a	 part	 of	 the	 normal	 flora	 of	 the	 respiratory	 tract,	 but	 is	 also	
associated	with	upper	and	lower	respiratory	tract	infections,	particularly	in	exacerbations	of	chronic	
obstructive	pulmonary	disease.	M.	catarrhalis	 is	 the	 third	most	 identified	 in	AOM	with	an	average	
frequency	of	detection	of	7.0%	and	less	frequently	in	rAOM	(4.1%)37.	Less	commonly,	M.	catarrhalis	
causes	 pneumonia,	 bacteraemia,	 periorbital	 cellulitis,	 neonatal	 meningitis,	 septic	 arthritis,	 and	
conjunctivitis.	











successful	 treatment	 of	 β	 lactamase	 positive	M.	 catarrhalis	 with	 penicillins253.	 The	 antibiotics	 of	












PCV7	vaccine,	 there	was	a	 replacement	of	vaccine	serotypes	with	 increased	S.	aureus	 colonization	






S.	 aureus	 is	 often	 identified	 in	 association	 with	 persistent	 otorrhea	 that	 follows	 insertion	 of	








inhibitory	 concentrations	 (MIC)	 of	 ≥4	 mcg/mL	 to	 oxacillin	 and	 is	 also	 resistant	 to	 all	 beta-lactam	
agents,	 including	 the	majority	 of	 cephalosporins	 (except	 ceftobiprole	 and	 ceftaroline).	Methicillin	
resistance	 is	 mediated	 by	 the	 mecA	 gene,	 which	 encodes	 for	 an	 abnormal	 low-affinity	 binding	
protein,	PBP-2a.	This	protein	allows	MRSA	strains	to	grow	and	divide	in	the	presence	of	methicillin	
and	 other	 beta-lactam	 antibiotics.	 The	mecA	 gene	 is	 located	 on	 a	mobile	 genetic	 element	 called	
staphylococcal	 cassette	 chromosome	 and	 dissemination	 of	 resistance	 is	 possible	 via	 horizontal	
transfer	of	the	mecA	gene	and	related	regulatory	sequences263,264.		
Oral	 antibiotics	 options	 in	 the	 treatment	 of	 MRSA	 include:	 clindamycin,	
trimethoprim/sulfamethoxazole	 and	 linezolid	 265.	 In	 the	 presence	 of	 a	 tympanic	 membrane	
perforation	 topical	 antibiotics	 containing	 gentamicin	 are	 also	 effective	 adjuvant	 treatments.	







P.	 aeruginosa	 is	 a	 Gram	 negative	 bacillus	 and	 is	 a	 facultative	 anaerobe.	 It	 is	 considered	 an	
opportunistic	 bacterium	 in	 patients	 who	 are	 immunocompromised,	 but	 is	 also	 associated	 with	
disease	for	immunocompetent	patients.	P.	aeruginosa	is	more	commonly	associated	with	colonizing	





P.	 aeruginosa	 is	 the	 most	 common	 bacterial	 pathogen	 in	 otitis	 externa269,	 in	 particular	 being	
isolated	 in	 61%	 of	 cases	 of	 malignant	 otitis	 externa	 and	 also	 being	 the	 most	 common	 cause	 of	
petrositis	 270.	 These	 characteristics	 suggest	 that	 P.	 aeruginosa	 may	 primarily	 be	 a	 bacteria	
originating	 from	the	external	auditory	canal	 that	can	cause	middle	ear	disease	via	a	perforation	 in	
the	tympanic	membrane.	
1.2.5.6.1 Antibiotic	susceptibility	
Fluoroquinolones	 are	 effective	 as	 first	 line	 topical	 treatment	 of	 suspected	 P.	 aeruginosa	 (or	
Staphylococcus	 aureus)	 otitis	 externa271	 with	 low	 levels	 of	 resistance.	 Ikeda	 et	 al.,	 reported	
fluoroquinolone	 resistance	 in	 12	 to	 28%	of	 the	 50	 clinically	 isolated	P.	 aeruginosa	 strains	 272,	 but	
suggested	 that	 3rd	 and	 4th	 generation	 fluoroquinolones	 remain	 effective,	 with	 sensitivity	 to	
garenoxacin,	 levofloxacin,	ciprofloxacin	and	sitafloxacin.	Additionally,	Kim	et	al.165	reported	on	471	
clinical	 P.	 aeruginosa	 strains	 isolated	 from	 patients	 with	 CSOM	 and	 found	 increasing	 rates	 of	
quinolone	antibiotic	resistance	from	2001	to	2013	at	their	 institution.	However,	they	also	reported	







The	 genus	 Corynebacterium	 comprises	 a	 collection	 of	 irregular-formed,	 rod-shaped	 or	 coccoid	
bacteria.	 Although	 some	 members	 of	 the	 genus	 are	 major	 pathogens	 e.g.	 Corynebacterium	
diptheriae	(the	etiological	agent	for	diphtheria),	the	species	frequently	grown	from	MEE	specimens	
are	of	low	pathogenic	potential.	In	fact,	it	has	been	suggested	that	some	strains	of	Corynebacterium	
may	 have	 a	 protective	 role	 against	 pathogenic	 bacteria	 such	 as	 S.	 aureus.	 For	 example,	 C.	
pseudodipheriticum	seems	to	be	able	to	prevent	colonization	of	the	anterior	nares	by	S.	aureus273.	
In	 the	 setting	of	OM,	Corynebacterium	spp.	 has	been	 reported	 in	5.1%274	 and	has	been	 identified	
from	 patients	 with	 chronic	 suppurative	 OM275.	 However,	 Corynebacterium	 spp.,	 which	 are	
considered	 commensals	 of	 the	 external	 ear	 canal175,	 may	 well	 play	 a	 similar	 role	 in	 the	 middle	
ear274.	
1.2.5.7.1 Antibiotic	susceptibility	
To	our	knowledge,	there	 is	no	 literature	addressing	the	treatment	of	Corynebacterium	spp.	 in	OM.	











As	discussed	above,	bacteria	are	cultured	 from	MEF	 in	only	40%	of	case	of	OME,	despite	 targeted	
PCR	revealing	the	presence	of	bacterial	DNA	in	80%	of	cases.	One	hypothesis	behind	the	 low	yield	
from	culture	 is	 that	 the	majority	of	 the	bacteria	within	 the	middle	ear	 exist	within	a	biofilm	 form.	
Since	 the	 demonstration	 of	 biofilm	 from	 the	middle	 ear	mucosa	 in	 children	 by	 Hall-Stoodley	 and	
colleagues162,	OM	has	been	considered	a	biofilm	driven	disease.	The	biofilm	model	of	disease	and	




phase277.	 While	 these	 two	 phases	 represent	 distinctly	 different	 phenotypical	 modes	 of	 bacterial	
existence,	 they	exist	on	a	continuum	 in	 the	 life	cycle	of	bacteria	and	are	 reflections	of	differential	









are	 subsequently	 able	 to	 exist	 in	 a	 coordinated,	 highly	 organised	 and	 stable	 physiological	 and	









fluctuations	 in	 temperature,	 oxygen	 tension,	 pH)	 and	 chemical	 (e.g.	 antibiotics)	 stressors	 but	 also	
against	 phagocytosis	 and	 humoral	 immunity280,281.	 Furthermore,	 there	 is	 evidence	 that	 bacterial	
species	within	polymicrobial	biofilm	can	confer	growth	advantages	and	increased	protection	to	each	




antibiotic	 concentrations	multitudes	 higher	 to	 eradicate	 than	 for	 the	 same	 bacteria	 in	 planktonic	
form280,287.	Some	of	the	recognised	mechanisms	behind	increased	resistance	in	biofilm	include:	the	
ability	of	 the	extracellular	matrix	 to	 impede	antibiotic	penetration,	decreased	metabolic	activity	of	
the	 bacteria	 within	 the	 biofilm,	 increased	 adaptation	 via	 quorum	 sensing,	 increased	 levels	 of	
mutations	 in	 antibiotic	 target	 molecules	 and	 upregulated	 antibiotic	 resistance	 genes288.	
Furthermore,	 the	 transfer	 of	 antibiotic	 resistance	 genes	 between	 bacteria	 has	 been	 identified	 as	
another	 potential	 mechanism	 by	 which	 bacteria	 can	 gain	 antibiotic	 resistance	 and	 growth	
advantage289.	 Studies	have	 shown	 that	 resistant	H.	 influenzae	 strains	 can	horizontally	 transfer	 ftsl	
genes	 (and	 thus	 resistance	 traits)	 to	 other	 H.	 influenzae	 strains290.	 	 Similarly,	 Armbruster	 and	






Additionally,	 infections	 caused	by	bacteria	 in	planktonic	 and	biofilm	 forms	manifest	with	different	
disease	 characteristics.	 Planktonic	 bacteria	 are	 associated	 with	 acute	 infection,	 whereas	 biofilm	
driven	disease,	is	more	indolent.	The	presence	of	biofilm	evokes	a	sustained	inflammatory	response	
from	 the	 host	 immune	 system,	 producing	 a	 persistent	 low-grade	 infection287.	 It	 is	 proposed	 that	
more	than	65%	of	bacterial	diseases	are	caused	by	bacteria	existing	in	biofilm	form291.	Biofilm	driven	
diseases	are	typified	by	a	chronic	illness	of	relapsing	and	remitting	course,	where	culture	of	bacteria	




The	 life	 cycle	 of	 biofilms	 closely	 resembles	 the	 natural	 history	 of	 OM,	 which	 is	 characterised	 by	
frequent	 spontaneous	 resolution,	 but	 also	 by	 high	 recurrence	 rates	 and	 persistence	 of	 bacteria	




In	 the	 setting	 of	 OM,	 the	 three	 most	 commonly	 recognised	 pathogenic	 agents,	 S.	 pneumoniae,	
nontypeable	H.	influenzae	(NTHi)	and	M.	catarrhalis,	have	been	shown	to	form	biofilms	in	vivo	294.	In	
addition,	biofilms	were	first	demonstrated	in	the	middle	ear	in	animal	models	of	OM295,296.	Post	et	
al.295	 investigated	 the	 potential	 for	H.	 influenzae	 to	 form	 biofilm	 in	 the	middle	 ear	 of	 Chinchillas.	
They	 injected	H.	 influenzae	 into	 the	middle	 ear	 clefts	 and	used	 scanning	 electron	microscopy	 and	







ear	 mucosa	 biofilm	 formation	 within	 24	 hours	 of	 inoculation	 that	 persisted	 up	 to	 21	 days.	 Since	






polymicrobial	 biofilms	 involving	 combinations	 of	 the	 three	 bacteria	were	 visualised.	 Furthermore,	
biofilm	 was	 not	 identified	 from	 control	 patients.	 Similarly,	 Thornton	 et	 al.299	 demonstrated	
multispecies	 biofilm	 from	 mucosal	 samples	 of	 20	 children	 both	 with	 OME	 and	 rAOM	 (65%	 of	
samples).	 Additional	 to	 demonstrating	 biofilm,	 the	 authors	 also	 imaged	 intracellular	 bacteria	
resembling	cocci	within	the	mucosal	epithelium	using	transmission	electron	microscopy.	They	note	




In	 addition,	 middle	 ear	 biofilm	 has	 been	 shown	 in	 patients	 with	 chronic	 suppurative	 OM	 and	









Otitis	media	with	 effusion	 is	 a	 highly	 prevalent	 childhood	 disease	 that	 carries	with	 it	 a	 significant	
morbidity	to	children	across	the	globe.	The	most	common	impact	of	untreated	OME	is	hearing	loss	
to	the	child,	with	an	associated	delay	in	both	social	and	learning	development.	These	sequelae	are	
especially	 pertinent	 in	 the	 Australian	 Aboriginal	 community,	 where	 there	 is	 a	 pre-existing	 gap	 in	
health	outcomes,	that	is	also	reflected	in	the	rates	of	OM.	
While	much	is	known	about	the	factors	contributing	OME,	there	remain	a	number	of	key	questions	
yet	 to	be	answered.	Both	host	and	environmental	 factors	contribute	 to	 the	development	of	OME.	
Host	 factors	 include	age,	 sex,	 inherited	predisposition	 to	OME	and	anatomical	 factors.	 In	addition,	
environmental	 factors	 such	 as	 pathogen	 exposure,	 tobacco	 smoke	 exposure,	 allergy,	 population	
density,	 seasonal	 variation	 and	 breastfeeding	 also	 play	 a	 role.	 Based	 on	 our	 current	 knowledge,	
these	 factors	 combine	 to	 contribute	 to	 Eustachian	 tube	 dysfunction.	 However,	 Eustachian	 tube	





most	 common	 cause	 of	 AOM,	 whilst	 H.	 influenzae	 is	 more	 commonly	 found	 in	 the	 middle	 ear	
aspirates	 of	 patients	with	 OME.	M.	 catarrhalis	 is	 the	 third	most	 commonly	 found	 bacteria	 and	 is	
associated	with	polymicrobial	 infection.	However,	with	 the	evolution	and	advancement	of	culture-
independent	 techniques,	 such	 as	 PCR	 and	 16srRNA	 gene	 sequencing,	 previously	 unidentified	







incidence	 and	 abundance	 of	 S.	 pneumoniae,	 H.	 influenzae	 and	 M.	 catarrhalis	 described	 in	 the	
literature.	 In	 contrast,	 A.	 otitidis	 is	 often	 not	 found	 in	 the	 nasopharynx,	 even	 in	 children	 with	
concurrent	otitis	media.	 It	 is	however	commonly	 isolated	from	the	external	ear	where,	to	date,	 its	
role	 is	considered	primarily	commensal.	There	 is	evidence	of	external	ear	canal	bacteria	such	as	S.	
aureus	and	P.	 aeruginosa	 causing	middle	 ear	 disease	by	 translocating	 from	 the	external	 ear	 canal	
into	 the	 middle	 ear	 following	 perforation	 of	 the	 tympanic	 membrane.	 Whether	 A.	 otitidis	 can	
translocate	into	the	middle	ear	and	play	a	pathogenic	role	is	yet	undetermined.	
Regardless	of	the	source	of	the	bacteria,	A.	otitidis	has	been	demonstrated	in	20-60%	of	middle	ear	
aspirates	 in	 OME,	 with	 evidence	 that	 it	 has	 pathogenic	 potential.	 In	 vivo	 studies	 have	 shown	 A.	
otitidis	 to	 have	 an	 immune-stimulatory	 potential	 on	 both	 myeloid	 and	 lymphoid	 cell	 types.	
Furthermore,	A.	 otitidis	has	 also	 been	 shown	 to	 induce	 otitis	media	with	 effusion	 in	 a	 rat	model.	
Additionally,	 A.	 otitidis	 has	 been	 implicated	 in	 cases	 of	 implant	 and	 chronic	 infection,	 which	 are	
typically	associated	with	biofilm	processes.	This	 is	 relevant	because	OM	 is	 thought	 to	be	a	biofilm	
driven	 disease,	with	 the	 persistent	 and	 recurrent	 nature	 of	OM	being	 typical	 of	 biofilm	 infection.	
Furthermore,	biofilm	has	been	directly	visualised	on	the	middle	ear	mucosa	in	patients	with	OME.	Of	
particular	interest	is	a	comment	by	Thornton	et	al.299,	who	identified	S.	pneumoniae,	H.	influenzae	
and	M.	 catarrhalis	 in	 biofilm	 from	middle	 ear	 mucosa	 samples	 using	 targeted	 FISH	 probes.	 They	
reported	 that	 when	 visualising	 the	 biofilm,	 that	 there	 remained	 a	 proportion	 of	 the	 biofilm	with	
unidentified	bacteria.	Whilst,	the	ability	of	A.	otitidis	has	not	been	investigated,	given	that	A.	otitidis	











2. Identify	 the	 bacterial	 reservoirs	 for	 the	 middle	 ear	 by	 comparing	 the	 microbiota	 of	 the	
middle	ear	with	that	of	the	adenoid	pad	and	external	auditory	canal	
3. Analyse	the	microbial	communities	within	the	middle	ear	to	further	understand	the	complex	
microbial	 relationships	 within	 the	 middle	 ear	 and	 to	 explore	 ways	 to	 manipulate	 this	
microbiome	























Conducted	 in	 the	 Department	 of	 Otolaryngology	 Head	 and	 Neck	 Surgery,	 University	 of	 Adelaide,	




















































Methods:	 Middle	 ear	 aspirates	 adenoid	 pad	 swabs	 were	 collected	 from	 twenty-three	 children	
undergoing	 ventilation	 tube	 insertion.	 Adenoid	 swabs	 from	 patients	 without	 ear	 disease	 were	
controls.	Samples	were	analysed	using	16S	rRNA	sequencing	on	the	Illumina	MiSeq	platform.	
Results:	 Thirty-five	 middle	 ear	 samples	 were	 collected.	 The	 middle	 ear	 effusion	 microbiota	 was	
dominated	by	Alloiococcus	(otitidis)	(23%	mean	relative	abundance),	Haemophilus	(22%),	Moraxella	















Otitis	media	with	effusion	(OME)	 is	the	most	common	cause	of	hearing	 loss	 in	childhood303.	 It	has	
been	 estimated	 that	 the	 point	 prevalence	 of	OME	 at	 age	 two	 is	 one	 in	 five	 children,	with	 four	 in	
every	5	children	affected	at	least	temporarily	by	the	age	of	10	years	303.	
The	pathogenesis	of	OME	 remains	unclear,	 although	 the	Eustachian	 tube	 (ET)	 is	 thought	 to	play	a	






been	 demonstrated	 within	 the	 middle	 ear132,304.	 One	 such	 emerging	 potential	 pathogen	 is	 A.	
otitidis,	 which	 has	 been	 isolated	 from	middle	 ear	 aspirates	 with	 increasing	 frequency	 in	 the	 last	
decade	182,194,305,306.	
The	 aim	 of	 this	 study	was	 to	 use	 culture	 independent	 techniques	 to	 compare	 the	 local	microbial	








Ethics	approval	was	obtained	 from	the	 institutional	 research	boards	of	 the	Women	and	Children’s	
Hospital	and	the	University	of	Adelaide	(approval	HREC/14/WCHN/42).		
2.3.1 Selection	Criteria	
Children	wait-listed	 for	ventilation	 tube	 (grommet)	 insertion	with	adenoidectomy	 for	chronic	OME	
(>3	months)	were	enrolled.	Control	patients	were	approached	if	they	had	no	history	of	otitis	media	
in	the	last	12	months	and	were	undergoing	other	forms	of	surgery	requiring	general	anaesthetic	and	
endotracheal	 intubation	 that	 was	 anatomically	 distant	 from	 the	 nasopharynx.	 Written	
parent/guardian	 consent	 was	 obtained	 prior	 to	 enrolment.	 Exclusion	 criteria	 included	 previous	
adenoidectomy,	acute	otitis	media,	resolved	effusions	or	upper	respiratory	tract	infection	at	time	of	
surgery,	 and	 antibiotic	 or	 steroid	 use	 in	 the	 four	 weeks	 preceding	 surgery.	 Demographic	 data	
including	 age,	 gender	 and	 parental	 smoking	 status	 as	 well	 as	 clinical	 data	 including:	 presenting	




of	 the	 planned	 procedure.	 All	 specimens	 were	 placed	 on	 ice	 immediately	 after	 collection	 and	
transferred	for	storage	in	a	-80°	freezer.	
2.3.2.1 Middle	ear	effusion	collection	















DNA	 extraction	 was	 carried	 out	 using	 PowerLyzer®	 PowerSoil®	 DNA	 Isolation	 Kit	 (MoBio	
Laboratories,	Salona	Beach,	CA).	Swab	heads	and	tissue	were	thawed	on	ice	and	placed	directly	on	
to	 the	beads	 for	homogenisation.	 Total	DNA	was	extracted	 from	all	 clinical	 samples	and	 two	DNA	




PCR	 amplification	 and	 sequencing	 was	 performed	 by	 the	 Australian	 Genome	 Research	 Facility	
(AGRF).		Libraries	were	generated	by	amplifying	the	V3–V4	(341F	–	806R)	hypervariable	region	of	the	
16S	 rRNA	 gene.	 PCR	 amplicons	 were	 generated	 using	 the	 primers	 CCTAYGGGRBGCASCAG	 in	 the	
forward	 sequence	 and	 GGACTACNNGGGTATCTAAT	 in	 the	 reverse	 sequence,	 using	 AmpliTaq	 Gold	
360	mastermix	(Life	Technologies,	Australia)	following	local	protocol.		The	resulting	amplicons	were	
measured	 by	 Fluorometry	 (Invitrogen	 Picogreen)	 and	 normalised.		 The	 equimolar	 pool	 was	 then	








sample,	 and	 quality	 filter	 the	 paired	 reads.	 Open-reference	 OTU	 picking	 strategy	 with	 pre	 filter	
threshold	 of	 0·80	 was	 used	 to	 cluster	 OTUs308.	 Within	 the	 open-reference	 method,	 UCLUST309	
v.1·2·22	 was	 used	 to	 cluster	 OTUs	 at	 97%	 similarity.	 	 SILVA	 (release	 111)310	 was	 used	 for	 the	
reference-based	step	of	the	OTU	picking	strategy	and	for	taxonomic	assignment	at	95%	similarity.		
2.3.6 Biostatistical	analysis	





Pursuant	 to	 rarefaction,	 all	 samples	 were	 subsampled	 to	 2000	 reads.	 Diversity	 estimates	 were	
performed	on	 subsampled	data.	 Simpson’s	 index	of	diversity	 (1-D)	was	used	 to	estimate	diversity.	
The	Simpson’s	index	of	diversity	takes	into	account	the	number	of	species	present,	and	their	relative	
abundance,	providing	a	value	between	0	and	1,	with	higher	numbers	 representing	a	more	diverse	
bacterial	 community.	 A	Mann	Whitney	 U-test	 was	 used	 to	 determine	 significance	 of	 variation	 in	
diversity	 across	 sample	 types.	 GraphPad	 v6	 (GraphPad	 Software	 Inc,	 California,	 USA)	was	 used	 to	
generate	box	plots	and	calculate	the	statistical	tests	used.		
Mean	relative	abundance	of	top	genera	were	calculated	for	the	middle	ear	fluid	(MEF),	adenoid	and	
control	 groups.	 The	mean	 of	 top	 genera	 in	 the	MEF,	 adenoid	 and	 control	 groups	were	 compared	
using	a	Wilcoxon	Signed	Ranks	Test,	Two	Samples	Students	T-Test	and	independent	samples	T-Test	





estimating	 the	 similarity	 between	 samples	 (with	 higher	 numbers	 representing	 greater	 similarity).	
The	 BC	 matrix	 was	 used	 to	 create	 a	 hierarchical	 group-average	 cluster	 analysis	 in	 PRIMER	 v6	
(PRIMER-E	Ltd,	Plymouth,	UK)312.	The	BC	matrix	was	also	used	to	summarise	the	distance	between	
MEF	 samples	 from	 the	 same	 patient	 (within	 patient),	 and	 the	 MEF	 samples	 from	 all	 patients	
(between	patient)	 in	QIIME.	A	 two-sided	Student's	 two-sample	 t-test	was	used	 to	 test	 significance	
between	 the	 within	 patient	 and	 between	 patient	 summaries.	 A	 permutational	 MANOVA	
(PERMANOVA)	 test	 was	 also	 performed	 in	 PRIMER	 to	 test	 whether	 there	 was	 a	 statistically	
significant	difference	between	the	bacterial	communities	in	the	MEF	and	the	adenoids	samples	(as	a	














Twenty-three	patients	 (14	male)	with	OME,	 aged	1-8	 years	 (mean	=	 40	months,	 SD	=	 21),	 and	10	
control	 patients	 aged	 1-12	 years	 (73	months,	 56),	 were	 recruited.	 Thirty-five	middle	 ear	 effusion	
samples	were	collected,	with	12	(60%)	OME	patients	presenting	with	bilateral	middle	ear	effusions.	
The	 control	 group	 included	 7	 patients	 undergoing	 laryngobronchoscopy	 for	 investigation	 of	






were	 highly	 variable	 between	 patients	 (fig	 2-1).	 The	 genera	 with	 the	 highest	 cumulative	 relative	
abundance	 was	 Alloiococcus	 (presumptive	 identification	 of	 OTUs	 classified	 to	 genus	 level	 as	
Alloiococcus	 using	 BLAST,	 confirmed	 >99%	 similarity	 to	 A.	 otitidis),	 with	 otopathogenic	 genera	
(Moraxella,	Haemophilus	and	Streptococcus)	also	well	represented	(table	1).	In	addition,	seven	MEF	











Inverse	 correlation	 was	 demonstrated	 between	 relative	 abundances	 of	 Alloiococcus	 and	
Haemophilus	 (p	=	0·049).	 In	addition,	 subgroup	analysis	demonstrated	 that	Alloiococcus	was	more	
abundant	in	unilateral	effusions	than	in	bilateral	effusions	(p	=	0·004,	Mann	Whitney	U-Test)	
Correlation	was	observed	between	 the	 relative	 abundance	of	 different	bacteria	within	 the	middle	









Prevalence Relative abundance 
Bacterial genera MEF (%) Adenoids 
(%) 
MEF (%) Adenoids (%) p value 
Aerobes: 
 	 	 	 	Alloiococcus 69 78 23 < 1 < 0·001 
Haemophilus 100 100 22 25 0·271 
Staphylococcus 66 87 11 < 1 0·004 
Corynebacteria 66 70 6 < 1 0·008 
Streptococcus 97 96 5 13 0·028 
Moraxella  89 96 5 14 0·271 
Neisseria 80 100 1 7 0·001 
Pseudomonas 68 not found 1 not found 0·017 
Anaerobes: 
 	 	 	 	Fusobacteria 100 100 4 11 0·002 
Porphyromonas 74 100 1 5 0·031 
Prevotella 69 100 < 1 3 0·005 
Enterobacteria 66 not found 2 not found 0·149 
Gemella 63 100 < 1 3 < 0·001 
Paraprevotella 46 100 < 1 2 0·001 
Veillonella 43 100 < 1 1 0·02 












anaerobic	 bacteria,	 orange:	 facultative	 anaerobic	 bacteria,	 blue:	 aerobic	 bacteria.	 The	 size	 of	 the	
circle	is	relative	to	the	number	of	correlations	with	other	bacteria.		
Legend:	 Allo	 –	Alloiococcus,	Hae	 –	Haemophilus,	Psu	 –	Pseudomonas,	 Str	 –	 Streptococcus,	
Ent	 –	 Enterobacteriaceae	 (family),	 Neiss	 –	Neisseria,	Gem	 –	Gemellaceae	 (family),	 Fuso	 –	










with	 common	 otopathogenic	 genera:	 Haemophilus	 (p	 =	 0·007),	 Streptococcus	 (p	 <	 0·001),	
Staphylococcus	(p	=	0·025),	and	Corynebacteria	(p	=	0·006)	using	paired	T-tests.	
	
Figure	 2-3	 Cluster	 analysis	 of	 the	 similarities	 between	MEF	 samples:	Hierarchical	Group	Average	














diversity	 between	 adenoid	 swabs	 from	 patients	with	OME	 and	 from	 control	 adenoid	 swabs	were	
similar.	 Thirteen	 of	 the	 seventeen	 most	 abundant	 bacterial	 genera	 demonstrated	 a	 significant	
difference	 in	 relative	 abundance	 between	 the	 different	 sites,	 with	 three	 bacterial	 families	
(Pseudomonas,	Enterobacteria	and	Caulobacteria)	only	demonstrated	 in	MEF	(table	2-1).	 	This	was	



























was	 a	 greater	 (non-significant)	 abundance	 of	 genera	 associated	 with	 middle	 ear	 disease	






















































Legend:	 Allo	 –	Alloiococcus,	Hae	 –	Haemophilus,	Psu	 –	Pseudomonas,	 Str	 –	 Streptococcus,	
Ent	 –	 Enterobacteriaceae	 (family),	 Neiss	 –	Neisseria,	Gem	 –	Gemellaceae	 (family),	 Fuso	 –	













We	 found	 that	 the	 microbiome	 of	 the	 middle	 ear	 consisted	 of	 six	 main	 genera	 of	 bacteria:	 (in	
descending	 order)	 Alloiococcus,	 Haemophilus,	 Staphylococcus,	 Corynebacteria,	 Streptococcus	 and	
Moraxella.	 These	 findings	 are	 consistent	 with	 previously	 published	 works	 using	 both	 traditional	





abundance	 demonstrated	 for	 Alloiococcus	 with	 <1%	 in	 the	 adenoid	 sample	 versus	 23%	 (most	
abundant)	 in	 the	 MEF.	 A.	 otitidis	 is	 commonly	 considered	 a	 commensal	 of	 the	 external	 canal	
38,175,315	 and	 has	 been	 reported	 as	 the	 most	 prevalent	 bacterial	 species	 in	 patients	 with	 non-
purulent	OME	(20	to	40%)	182,197,315.	Our	findings	are	consistent	with	the	literature,	with	A.	otitidis	
















specific	body	sites153,155	and	 that	 the	composition	at	each	site	 remains	 relatively	stable	over	 time	
153,155,156.	 These	 findings	 imply	 that	 a	 core	microbiota	exist	within	body	niches	and	 that	 they	are	
somewhat	resistant	to	external	factors.	Whilst	our	study	design	precluded	longitudinal	analysis	(only	
five	 patients	 have	 required	 repeat	 tympanostomy	 tube	 insertion	 to	 date),	 we	 believe	 that	 this	 is	
likely	true	of	the	middle	ear	as	well.	
In	 our	 patients,	 we	 found	 that	 core	 bacteriology	 of	 OME	 involves	 complex	 polymicrobial	
communities	rather	than	merely	the	presence	of	dominant	bacteria.	Only	a	minority	of	MEF	samples	
displayed	a	dominant	species	and	even	in	these	cases	there	were	traces	of	other	bacteria.	Moreover,	
we	 observed	 a	 correlation	 in	 relative	 abundance	 between	multiple	 genera,	 particularly	 anaerobic	
and	 facultative	 anaerobic	 bacteria.	 Interestingly,	 a	 similar	 correlation	 was	 also	 observed	 in	 the	
adenoid	 tissue.	 One	 possible	 explanation	 for	 this	 is	 the	 high	 prevalence	 of	 bacterial	 biofilms	
demonstrated	 in	 both	 middle	 ear	 effusions	 and	 adenoid	 tissue162.	 These	 three	 dimensional	






Based	on	 the	 findings	of	 this	 study,	we	propose	a	microbiome	model	of	 the	pathogenesis	of	otitis	
media.	We	postulate	 that	 the	microbiome	of	 the	healthy	middle	ear	 is	 likely	distinctly	different	 to	
that	 in	 the	 setting	 of	 OME	 and	 also	 to	 that	 of	 acute	 otitis	 media.	 We	 believe	 that	 adenoidal	
hypertrophy	 and	 Eustachian	 tube	 dysfunction	 predispose	 to	 OME	 resulting	 in	 the	 formation	 of	 a	
stable	 OME	 microbiome	 (and	 likely	 biofilm),	 similar	 to	 that	 described	 in	 this	 paper.	 However,	
subsequent	changes	in	the	local	environment	within	the	middle	ear,	whether	via	direct	inflammation	
(for	example,	secondary	to	viral	infection320)	or	host	immunomodulation,	creates	a	disequilibrium	of	
the	 local	microbiota,	 thus	 resulting	 in	 the	emergence	of	 a	dominant	 species	and	potentially	 acute	
disease.	For	example,	when	the	micro-environment	favours	the	classic	otopathogens	(H.	influenzae,	




Finally,	 the	 similarity	 of	 the	 microbiota	 of	 the	 MEF	 and	 external	 ear	 canal;	 in	 particular	 high	
prevalence	of	Alloiococcus,	Staphylococcus	and	Corynebacterium	is	reported	in	the	literature175.	This	
does	raise	the	question	of	whether	the	external	ear	itself	may	act	as	a	reservoir	for	the	middle	ear.	
Although,	 bacterial	 translocation	 through	 an	 intact	 healthy	 tympanic	 membrane	 would	 seem	
unlikely,	 contamination	 through	 macro-	 or	 micro-perforations	 cannot	 be	 excluded.	 Furthermore,	
















The	 microbiome	 of	 the	 middle	 ear	 in	 OME	 is	 diverse	 with	 both	 aerobic	 and	 anaerobic	 bacteria	
represented.	A.	otitidis	is	found	in	high	abundance	and	may	play	a	major	role	in	the	pathogenesis	of	
OME,	 especially	 unilateral	 effusions	 and	 displays	 an	 inverse	 relationship	 with	 Haemophilus.	
Furthermore,	dissimilarities	between	the	 local	microbiota	of	 the	adenoid	and	the	middle	ear	were	
demonstrated,	suggesting	 that	 the	microenvironment	of	 the	middle	ear	plays	a	greater	 role	 in	 the	

























Conducted	 in	 the	 Department	 of	 Otolaryngology	 Head	 and	 Neck	 Surgery,	 University	 of	 Adelaide,	


















































Methods:	Middle	ear	aspirates	and	external	 canal	 lavages	were	collected	 from	children	with	otitis	
media	 with	 effusion	 undergoing	 ventilation	 tube	 insertion	 in	 two	 consecutive	 years	 (2014-2015).	




(otitidis)	 (38.5%	mean	relative	abundance),	Haemophilus	 (14.4%),	Moraxella	 (10%),	Staphylococcus	
(8.2%)	and	Streptococcus	(3.8%).	The	microbiota	of	the	external	ear	canal	demonstrated	a	sparsity	of	
classic	 otopathogens	 (Haemophilus,	 Moraxella,	 Streptococcus),	 but	 had	 high	 abundance	 of	
Alloiococcus	(58%),	Staphylococcus	(20.8%)	and	Pseudomonas	(3.2%).	In	contrast,	based	on	previous	
collected	 data,	 the	 microbiota	 of	 the	 adenoid	 pad	 showed	 high	 abundance	 of	 the	 classic	
otopathogens	with	a	 sparsity	of	external	 canal	genera.	The	microbiota	of	 the	middle	ear	collected	
over	two	consecutive	years	were	similar.	
Conclusion:	Both	the	external	auditory	canal	and	the	nasopharynx	could	serve	as	reservoirs	for	the	









influenza.	 These	 bacteria	 are	 commensals	 within	 the	 oro-	 and	 naso-pharynx	 and	 it	 is	 commonly	
believed	 that	 these	 pathogens	 ascend	 from	 the	 aerodigestive	 tract	 into	 the	 middle	 ear	 via	 the	
Eustachian	tube303.	
In	 recent	 times,	 with	 the	 increasing	 interest	 in	 and	 access	 to	 culture	 independent	 techniques	




We	recently	characterised	 the	microbiome	of	 the	middle	ear322	and	 found	that	A.	otitidis	was	 the	
most	 abundant	 bacteria	 found	 within	 middle	 ear	 effusions	 of	 children	 (23%	 cumulative	 relative	












This	 study	was	 conducted	 following	 ethics	 approval	 from	 the	 institutional	 research	 boards	 of	 the	
Women	 and	 Children’s	 Hospital	 and	 the	 University	 of	 Adelaide	 (approval	 HREC/14/WCHN/42).	
Collection	of	tissue	was	carried	out	over	the	Australian	winter	period	(June	–	September)	2015.	All	
patients	 were	 aged	 between	 1-16	 years	 of	 age,	 with	 written	 parental/guardian	 consent	 obtained	
prior	to	enrolment.	Children	wait-listed	for	ventilation	tube	(grommet)	insertion	+/-	adenoidectomy	
























DNA	 extraction	 was	 carried	 out	 using	 PowerLyzer®	 PowerSoil®	 DNA	 Isolation	 Kit	 (MoBio	
Laboratories,	Salona	Beach,	CA).	Samples	were	thawed	on	ice	and	placed	directly	on	to	the	beads	for	
homogenisation.	Total	DNA	was	extracted	from	all	clinical	samples	and	two	DNA	extraction	negative	
controls	 containing	 extraction	 reagents	 only.	 The	 remainder	 of	 the	 extraction	 protocol	 was	
performed	as	per	the	manufacturer’s	protocol.	Extracted	DNA	was	stored	at	-80oC	until	sequencing.		
3.3.4 PCR	amplification	of	the	16S	rRNA	gene	and	sequencing	
PCR	 amplification	 and	 sequencing	 was	 performed	 by	 the	 Australian	 Genome	 Research	 Facility	
(AGRF).		Libraries	were	generated	by	amplifying	the	V3–V4	(341F	–	806R)	hypervariable	region	of	the	
16S	 rRNA	 gene.	 PCR	 amplicons	 were	 generated	 using	 the	 primers	 CCTAYGGGRBGCASCAG	 in	 the	
forward	 sequence	 and	 GGACTACNNGGGTATCTAAT	 in	 the	 reverse	 sequence,	 using	 AmpliTaq	 Gold	
360	mastermix	(Life	Technologies,	Australia)	following	local	protocol.		The	resulting	amplicons	were	













v.1·2·22	was	 used	 to	 cluster	 OTUs	 at	 97%	 similarity.	 The	 Greengenes	 16S	 database	was	 used	 for	
reference-based	 OTU	 picking	 and	 for	 taxonomic	 assignment.	 Taxonomic	 assignment	 for	 all	 other	
OTUs	 remained	at	 genus-level	during	 taxonomic	assignment.	All	 samples	were	 subsampled	 to	950	
reads	(rarefaction).	Diversity	estimates	were	performed	on	subsampled	data.	
3.3.6 Biostatistical	analysis	
Shannon’s	 index	 of	 diversity	was	 used	 for	 alpha	 diversity.	 A	 Friedman	 rank	 sum	 test	was	 used	 to	
determine	 whether	 a	 significant	 difference	 of	 alpha	 diversity	 between	 sample	 types	 (while	
controlling	for	the	repeated	measure	of	“side	in	patient”).	
Distance	matrices	for	beta	diversity	metrics	(Bray-Curtis,	unweighted	UniFrac,	and	weighted	UniFrac)	
were	 generated	 using	 QIIME.	 Distances	 in	 these	matrices	 were	 used	 to	 calculate	mean	 distances	
within-	and	between-	sample	type	groups.	Mean	“within-sample	type”	and	“between-sample	type”	




Species	 level	 presumptive	 identification	was	performed	on	OTUs	 classified	as	A.	otitidis,	 using	 the	







Pearson’s	 GraphPad	 v6	 (GraphPad	 Software	 Inc,	 California,	 USA)	 was	 used	 to	 analyse	 the	 data,	
generate	box	plots	and	calculate	the	statistical	 tests	used.	Mean	relative	abundance	of	top	genera	
were	 calculated	 for	 the	middle	 ear	 fluid	 (MEF),	 external	 ear	 canal	 (EAC)	 groups.	 The	mean	of	 top	
genera	from	these	two	sites	were	compared	using	a	paired	T-test.	Correlation	between	genera	was	









of	 the	patients	were	male.	3	patients	 (17%)	had	undergone	previous	ventilation	tube	 insertion.	16	
patients	 had	 bilateral	 effusions	 (total	 number	 of	 MEF	 samples	 =	 34).	 No	 patients	 were	 primary	
smokers,	although	one	patient	co-habitated	with	at	least	one	carer	who	smoked.	
3.4.1 Microbiome	of	middle	ear	with	effusion	
The	 genera	 of	 bacteria	 that	 occurred	 at	 greater	 than	 or	 equal	 to	 1%	mean	 (cumulative)	 relative	
abundance	 were:	 Alloiococcus	 (38.5%),	 Haemophilus	 (14.4%),	Moraxella	 (10.0%),	 Staphylococcus	
(8.2%),	Streptococcus	(3.8%),	Corynebacteria	(3.1%)	and	Pseudomonas	(3.1%)	(Table	3-1,	figure	3-1).	
Genera	occurring	at	less	than	1%	were	reported	as	absent,	due	to	the	potential	for	background	noise	
confounding	 these	 findings.	 Furthermore,	 Alloiococcus	 shared	 an	 inverse	 correlation	 relationship	
with	Staphylococcus	(Pearson	correlation	co-efficient	(r)	=	-0.433,	p	=	0.011)(figure	3-2).		
3.4.2 Microbiome	of	the	external	ear	canal	
The	 genera	 of	 bacteria	 that	 occurred	 at	 greater	 than	 1%	 mean	 (cumulative)	 relative	 abundance	
were:	Alloiococcus	 (58%),	Staphylococcus	 (20.8%),	Pseudomonas	 (3.2%),	Corynebacteria	 (2.8%)	and	
Enterobacteria	 (1.4%).	 Haemophilus	 (0.3%),	 Moraxella	 (0.3%),	 Streptococcus	 (0.2%)	 were	 less	
abundant,	despite	prevalence	ranging	from	17-31%	(Table	3-1,	figure	3-1).		
There	were	inverse	correlation	relationships	between	the	relative	abundance	of	bacterial	genera	(fig	
2):	Alloiococcus	with	 Staphylococcus	 (r	 =	 -0.787,	 p	 <	 0.001),	Haemophilus	 (r	 =	 -0.356,	 p	 =	 0.039),	
Moraxella	 (r	 =	 -0.456,	 p	 =	 0.007)	 and	 Streptococcus	 (r	 =	 -0.419,	 p	 =	 0.014).	 Haemophilus	 shared	











Legend:	 Allo	 –	Alloiococcus,	 Staph	 –	 Staphylococcus,	Coryne	 –	Corynebacterium,	Pseudo	 –	











EAC	 MEF	 Adenoids	 EAC	 MEF	 Adenoids	
Haemophilus	 14.3	 31.4	 100.0	 0.3	 14.4	 25.0	
Moraxellla	 17.1	 20.0	 96.0	 0.3	 10.0	 14.0	
Streptococcus	 11.4	 17.1	 96.0	 0.2	 3.8	 13.0	
		
	 	 	 	 	
		
Alloiococcus	 74.3	 65.7	 78.0	 58.0	 38.6	 0.1	
Staphylococcus	 51.4	 37.1	 87.0	 21.8	 8.1	 0.2	




























The	microbiome	 of	 the	 two	 sites	 were	 dissimilar	 (figure	 3-1).	 The	microbiome	 of	 the	middle	 ear	








p	 <	 0.001).	 However,	 despite	 overall	 dissimilarities	 between	 the	 two	 areas,	 there	 was	 positive	
correlation	 between	 bacterial	 genera	 commonly	 associated	 with	 external	 canal	 commensals:	
Alloiococcus	 (Pearson	 r	 =	 0.680,	 p	 <	 0.001),	 Staphylococcus	 (0.868,	 p<	 0.001)	 and	 Corynebacteria	











(male	74%	vs	66%	p	=	0.84).	 The	microbiome	of	 the	middle	ears	was	 similar	when	comparing	 the	
2014	 to	 the	2015	 cohort	 (One-way	ANOVA	p	<	0.001)	 (fig	3-4),	 however	on	 further	analysis	 there	
was	a	greater	relative	abundance	of	Alloiococcus	 in	the	second	year	(23%	vs	38.5%	Sidaks	multiple	
comparisons	test,	p	<	0.05).	








there	 were	 significant	 differences	 in	 relative	 abundance	 for	 Alloiococcus,	 Haemophilus,	
Streptococcus,	Moraxella	and	Staphylococcus	(p	<	0.05).		
	
Figure	 3-3	 Microbiome	 of	 bilateral	 ear	 effusions.	 Graphical	 representation	 of	 the	 mean	 relative	
abundance	 of	microbiota	 when	 comparing	 between	 left	 and	 right	 ears	 for	 patients	 with	 bilateral	
effusions	








Figure	 3-4	Microbiome	 of	 the	middle	 ear	 over	 time.	Graphical	 representation	 of	 the	 cumulative	
relative	 abundance	 of	 microbiota	 found	 in	 middle	 ear	 effusions	 when	 comparing	 two	 cohorts	 of	
patients	over	consecutive	years	with	otitis	media	with	effusion	








This	 is	 a	 follow	up	 study	 to	our	previously	published	 study322,	which	was	 the	 first	 to	describe	 the	




pathogens	 (Moraxella,	 Haemophilus	 and	 Streptococcus)	 also	 present	 in	 abundance.	 The	 only	
significant	difference	was	that	there	was	an	increase	in	the	mean	relative	abundance	of	Alloiococcus	
in	 the	second	year.	The	reason	 for	 this	difference	 is	unclear,	but	may	reflect	a	natural	variation	 in	
commensal	 carriage	 of	 the	 external	 canal/middle	 ear	 cleft	 between	 populations.	 Alternatively,	 as	
discussed	above,	there	was	a	greater	number	of	patients	with	previous	myringotomy	in	our	second	




consequently	 do	 not	 exhibit	 a	 proportional	 rise	 in	 abundance.	 Despite	 this	 variation	 in	 relative	
abundance,	we	believe	that	bacteria	genera	identified	from	the	middle	ears	of	our	cohort	reflect	a	
‘core’	 microbiome	 of	 the	 middle	 ear,	 which	 remains	 relatively	 stable	 over	 time	 and	 between	
different	populations,	a	characteristic	which	has	been	reported	at	other	body	sites325,326.		
Our	findings	support	those	of	a	previous	culture-independent	phylogenetic	study	by	Frank	et	al.327.	
Despite	 differences	 in	 sampling	 techniques,	 geographical	 location	 and	 seasonal/climatic	 factors,	
Frank	et	al.	 also	demonstrated	a	major	abundance	of	Alloiococcus	 (57%).	Their	 study	also	 showed	






Interestingly,	we	 found	 that	 the	microbiome	of	 the	middle	ear	 in	OME	appear	 to	 reflect	both	 the	
microbiome	of	 the	adenoid	pad	and	 the	external	 canal	microbiomes	 (fig	1,	 table	1).	Haemophilus,	
Streptococcus	and	Moraxella	were	in	high	abundance	in	both	the	adenoids	and	the	middle	ear	but	
absent	(<1%)	in	the	external	canal.	Conversely,	Alloiococcus,	Staphylococcus	and	Pseudomonas	were	





has	 not	 been	 demonstrated.	 In	 health,	 the	 tympanic	 membrane	 has	 been	 shown	 to	 only	 allow	
oxygen	 and	 carbon	 dioxide	 to	 diffuse	 through	 it330.	 This	 is	 largely	 due	 to	 its	 multi-layered,	
multicellular	structure,	consisting	of:	epidermis	(external	layer),	a	radiating	layer	of	collagen	fibres,	a	
circular	 layer	 of	 collagen	 fibres	 and	 layer	 of	 simple	 cuboidal	 epithelium	 (middle	 ear	 mucosa).	
Furthermore	during	acute	 infections	 the	 thickness	of	 the	 tympanic	membrane	 	has	been	 found	 to	
increase	in	thickness	further,	due	to	oedema	and	inflammation331.		
Given	 the	above,	 it	would	 seem	 that	 the	presence	of	 a	 tympanic	perforation	would	be	needed	 to	
facilitate	 entry	 of	 bacteria	 from	 the	 external	 canal	 into	 the	 middle	 ear.	 Epidemiological	 studies	
suggest	that	almost	80%	of	children	will	suffer	an	episode	of	acute	otitis	media	by	age	three6,	with	
perforations		reported	in	up	to	30%	of	such	cases3.	It	is	not	unforeseeable	then,	that	such	an	episode	
could	 be	 responsible	 for	 the	 translocation	 of	 external	 ear	 canal	 bacteria	 observed	 in	 our	 study.	
Unfortunately,	a	past	history	of	perforation	was	not	obtained	from	our	patient	cohort,	therefore	this	
cannot	 be	 commented	 on	 directly.	 However,	 as	 mentioned	 above,	 we	 observed	 a	 statistically	





compared	with	 the	 first.	 This	 finding	may	 potentially	 reflect	 the	 greater	 number	 of	 patients	with	
previous	ventilation	tube	insertion	[6%	(1/17	patients)	in	the	first	study	vs	17%	(3/18)	in	the	second],	
thus	allowing	 for	a	greater	chance	of	external	 canal	bacteria	 translocating	 in	 to	 the	middle	ear.	 In	
fact,	 examples	 of	 external	 ear	 canal	 commensals	 causing	 middle	 ear	 disease	 via	 perforation	 is	
evident	 in	 the	 frequent	 bacterial	 culture	 of	 P.	 aeruginosa	 and	 S.	 aureus	 in	 cases	 of	 chronic	
suppurative	otitis	media332,333.		
Yet,	 unlike	 P.	 aeruginosa	 and	 S.	 aureus,	 the	 role	 of	A.	 otitidis	 in	 otitis	media	 remains	 unclear.	A.	
otitidis	is	an	aerobic,	gram-positive	cocci	first	documented	in	MEF	by	Faden	and	Dryja	in	1989	188.	It	
is	 commonly	 considered	 a	 commensal	 of	 the	 external	 canal	 and	 is	 not	 commonly	 identified	 with	
standard	 techniques38,182,194,198.	 However,	 potential	 for	 pathogenicity	 has	 been	 documented:	A.	
otitidis	 has	 been	 found	 to	 invade	 intracellularly188,	 to	modulate	 immune	 responses	 in	 vitro211,334	
and	has	been	implicated	in		cases	of	endocarditis219,	and	endopthalmitis	217.	In	addition,	A.	otitidis	is	
the	most	prevalent	bacterial	 species	 found	 in	patients	with	non-purulent	OME	 (20	 to	40%)	181-183	
and	 has	 been	 reported	 to	 persist	 within	 middle	 ear	 aspirates	 despite	 antibiotic	 treatment194.	
However,	the	impact	and	role	of	Alloiococcus	 in	the	pathogenesis	or	development	of	OME	remains	
elusive.	 Yet,	 we	 believe	 that	 further	 investigation	 to	 elucidate	 the	 role	 of	 Alloiococcus	 in	 OME	 is	
warranted.	
However,	given	the	similarity	between	the	microbiome	of	the	external	ear	canal	and	middle	ear,	the	
possibility	 of	 contamination	 must	 be	 considered.	 We	 believe	 this	 is	 less	 likely	 for	 the	 following	
reasons.	Firstly,	to	reduce	contamination	prior	to	myringotomy	and	aspiration,	the	external	canal	is	
first	 toileted	 and	 washed.	 The	 aspiration	 technique	 itself	 then	 avoids	 any	 external	 canal	 contact,	
with	minimal	contact	with	the	tympanic	membrane	 itself	 (video	1).	Although	there	 is	a	 theoretical	



















































































condition	 remains	 unclear.	 Recent	 studies	 have	 observed	 an	 inverse	 relationship	 between	 the	
relative	abundance	of	A.	otitidis	and	H.	influenzae	within	middle	ear	aspirates.	The	aim	of	this	study	
was	to	characterize	A.	otitidis	and	investigate	the	relationship	between	these	two	bacteria	in	vitro.	
Methods:	 The	 ability	 of	A.	 otitidis	 to	 form	 both	 single-species	 and	 polymicrobial	 biofilms	with	H.	
influenzae	 reference	 strains	 and	 clinical	 isolates	was	 explored.	 Biofilm	was	 imaged	 using	 confocal	
scanning	laser	microscopy	and	scanning	electron	microscopy.	Quantification	of	biofilm	biomass	and	
bacterial	 volume	was	 assessed	 using	 a	 crystal	 violet	 assay	 and	 viable	 cell	 counting.	 Antimicrobial	
sensitivity	was	assessed	using	a	microdilution	method	and	E-test	for	amoxicillin	and	ciprofloxacin.		
Results:	 A.	 otitidis	 was	 able	 to	 form	 both	 single-species	 and	 polymicrobial	 biofilms	 with	 H.	
influenzae.	 A.	 otitidis	 promoted	 H.	 influenzae	 persistence	 and	 survival	 by	 increasing	 biofilm	










Alloiococcus	 otitidis	 (A.	 otitidis)	 is	 a	 commonly	 identified	 bacteria	 within	 middle	 ear	 aspirates	 of	
children	with	chronic	otitis	media	with	effusion	(COME).	In	the	past,	A.	otitidis	had	been	considered	




Recently,	 using	 culture-independent	 16S	 rRNA	 sequencing,	we	 confirmed	 that	A.	 otitidis	 is	 indeed	
the	most	abundant	bacteria	in	middle	ear	aspirates	from	two	cohorts	of	children	with	COME335,336.	
Additionally,	 we	 found	 an	 inverse	 correlation	 between	 the	 relative	 abundance	 of	 non-typeable	








OM	 could	 be	 a	 biofilm	 driven	 disease162,299.	 Biofilms	 are	 complex	 three	 dimensional	 structures	
made	of	extracellular	DNA,	bacterial	cells	and	the	extracellular	polysaccharide	(EPS)	matrix	that	they	
produce.	 The	 EPS	 matrix	 encloses	 the	 bacterial	 cells	 and	 allows	 irreversible	 attachment	 to	 a	
substratum,	 an	 interface	 or	 to	 each	 other280.	 The	 formation	 of	 biofilm	 is	 significant,	 as	 bacteria	





have	 an	 increased	 antibiotic	 resistance280,281.	 	 Moreover,	 bacteria	 in	 polymicrobial	 biofilms	 have	
been	 shown	 to	 further	 reinforce	 this	 protection	 through	 quorum	 sensing	 and	 the	 transfer	 of	
antibiotic	resistance	genes	between	strains283-286.	



















The	 biofilm	 forming	 H.	 influenzae	ATCC	 33391	was	 purchased	 from	 ATCC.	 Also,	 two	 clinical	 NTHi	
strains	 designated	 NT176	 and	 NT1159,	 both	 from	 middle	 ear	 isolates,	 were	 obtained	 from	 the	










were	counted	after	 incubating	for	3	days	 in	normal	atmosphere.	H.	 influenzae	was	enumerated	on	










This	 was	 equivalent	 to	 a	 starting	 suspension	 of	 2.0	 X	 107	 single	 colony	 forming	 units	 per	 mL	
(SCFU/mL)	of	A.	otitidis,	1.4	X	108	SCFU/mL	of	ATCC	33391,	4.2	X	107	SCFU/mL	of	NT	176	and	4.8	X	





























In	 addition,	 as	 described	 above,	 the	 co-culture	 biofilm	 assay	 was	 repeated	 with	 both	 bacteria	
suspended	 in	 either	 BHI	 only,	 BHI	 with	 factor	 X	 only	 and	 BHI	 with	 factor	 V	 only.	 Furthermore,	 a	






µL	 of	 crystal	 violet	 10%w/w	 and	 allowed	 to	 incubate	 at	 room	 temperature	 for	 15	 mins.	 For	














were	 fixed	 for	 15	minutes	 in	 2.5%	 glutaraldehyde	 at	 room	 temperature,	 followed	 by	 fluorescent	
staining	for	15	minutes	at	room	temperature	with	SYTO	9	(1	µL/mL)	and	propidium	iodide	(1	µL/mL)	




Multi-species	 biofilms	were	 grown	 for	 168	 hours	 on	 pegs	 in	 the	 Calgary	 Biofilm	Device	 under	 the	
conditions	 mentioned	 above.	 Biofilms	 on	 pegs	 were	 washed	 with	 PBS,	 fixed	 with	 2.5%	
glutaraldehyde	and	exposed	to	1%	osmiumtetroxide,	followed	by	a	dehydration	series	ranging	from	
50%	 to	 100%	 ethanol.	 The	 final	 dehydration	 step	 was	 repeated	 twice	 before	 addition	 of	
hexamethyldisilazane	to	preserve	the	biofilm	structure.	Biofilms	on	pegs	were	then	sputter-coated	




sensitive	 (S)	 or	 resistant	 (R)	 as	 follows	 for	 H.	 influenzae:	 amoxicillin	 S	 ≤	 2	 μg/mL,	 R	 >	 2	 μg/mL,	






to	 interpret	 the	 results	 as	 previously	 reported347:	 amoxicillin	 S	 ≤	 0.06	 μg/mL,	 R	 ≥	 2	 μg/mL,	
ciprofloxacin	S	≤	0.125	μg/mL,	R	≥	2	μg/mL.		
4.3.5.1 Planktonic	assays	
Modified	 minimum	 inhibitory	 concentration	 assays	 as	 previously	 described348	 were	 carried	 out.	
50µL	of	H.	influenzae	alone,	A.	otitidis	alone,	or	H.	influenzae	and	A.	otitidis	together	were	added	to	





Further,	 antibiotic	 testing	 was	 carried	 out	 by	 E-Test®	 (bioMérieux,	 SA,	 Marcy	 l'Etoile,	 France)	
following	 the	 EUCAST	 guidelines276.	 Again	 combinations	 of	 H.	 influenzae	 and	 A.	 otitidis	 were	
investigated	 as	 above.	 These	 techniques	 are	 not	 calibrated	 for	 A.	 otitidis;	 therefore	modifications	
were	made	to	obtain	sufficient	growth	of	this	species.	BHIb	agar	was	utilized	for	testing	of	A.	otitidis	
alone,	 and	BHIs	was	used	 for	 testing	of	H.	 influenzae	 and	when	H.	 influenzae	was	 in	 combination	















Pearson’s	 GraphPad	 v6	 (GraphPad	 Software	 Inc,	 California,	 USA)	 was	 used	 to	 analyze	 the	 data,	
generate	box	plots	 and	 calculate	 the	 statistical	 tests	 used.	 The	 student	 t-test	 (two-tailed,	 unequal	







but	 were	 larger	 when	 grown	 in	 BHIb.	 Peak	 growth	 of	 bacteria	 in	 broth	 was	 at	 24	 hours	 post	
incubation	 for	both	media.	There	were	a	greater	number	of	viable	cells	 in	BHIb	than	 in	BHIs	at	12	
hours	(BHIb,	Mean	[SD]	=	7.7	x	106,	[3.1	x	106]	vs	BHIs,	1.0	x	106	[7.5	x	105],	p	=	0.02)	24	hours	(BHIb,	
6.7	x	107	[1.2	x	107]	vs	BHIs,	9.0	x	106	[1.0	x	106],	p	=	0.001)	and	48	hours	(BHIb,	3.2	x	107	[1.6	x	107]	

























in	BHIs	 (B)	 at	 X63	magnification.	 Live/Dead	Baclight	Bacterial	Viability	 staining	was	used:	 live	 cells	








All	 three	strains	of	H.	 influenzae	 formed	biofilm	 in	BHIs.	When	co-cultured	with	A.	otitidis	 in	BHIs,	
polymicrobial	biofilm	was	observed	with	all	three	strains.	In	these	polymicrobial	biofilms,	A.	otitidis	






reminiscent	of	 those	demonstrated	when	A.	otitidis	was	cultured	alone	 in	BHIb	 (Figure	4-3A-C).	A.	
otitidis	biofilm	(Figure	4-4A)	and	polymicrobial	biofilms	(Figure	4-4B)	were	furthermore	visualised	by	





In	 contrast,	 when	H.	 influenzae	 was	 cultured	 in	 suboptimal	 conditions	 (i.e.	 BHI	 in	 the	 absence	 of	
factor	V	or	X	or	growth	at	30°C),	the	addition	of	A.	otitidis	 increased	the	total	number	of	viable	H.	
influenzae	cells	and	the	total	biofilm	biomass.	No	biofilm	was	demonstrated	at	24	hours	in	BHI	only,	
for	 either	H.	 influenzae	 only,	 H.	 influenzae	 with	A.	 otitidis	 or	A.	 otitidis	 only	 (results	 not	 shown).	


















biofilm.	 CSLM	 of	 multispecies	 biofilm	 in	 BHIs	 at	 63X	 magnification,	 after	 LIVE/DEAD	 Baclight	
Bacterial	 Viability	 staining	 consisting	 of	A.	 otitidis	 (Green	 cocci,	 arrows)	 and	H.	 influenzae	 (mixed,	




















Figure	 4-6	 H.	 influenzae	 growth	 alone	 and	 in	 combination	 with	 A.	 otitidis	 in	 reduced	 media.	
Quantification	of	H.	 influenzae	ATCC	33391	 (ATCC)	biofilm	alone	and	 in	 the	presence	of	A.	otitidis	
(AO)	 in	 reduced	 brain	 heart	 infusion	 media;	 with	 added	 Factor	 V	 (A-B)	 or	 Factor	 X	 (C-D).	 Panels	






















compared	 with	 clinical	 breakpoint	 guidelines276,	 both	 alone	 and	 in	 combination	 with	 the	 H.	
influenzae	strains	(clinical	breakpoints	MIC	≤0.06	μg/mL	and	S	≤	0.125	μg/mL	respectively)	(Table	1).		
Interestingly,	when	A.	otitidis	was	co-cultured	with	the	H.	influenzae	strains,	there	was	a	change	in	
the	 MIC	 for	 some	 combinations.	 For	 amoxicillin,	 the	 MIC	 for	 A.	 otitidis	 alone	 was	 0.016	 μg/mL.	































Minimum	 inhibitory	 concentrations	 (MIC)	 and	 Minimum	 Bactericidal	 Concentration	 (MBC)	 for	 A.	
otitidis	(AO)	planktonic	and	biofilm	antibiotic	susceptibility	respectively.	MIC	was	assessed	by	E-test	




















In	biofilm	 form,	 for	amoxicillin,	 the	MBC	of	all	 three	H.	 influenzae	strains	were:	ATCC	=	32	μg/mL,	

















Table	 4-2:	 Minimum	 inhibitory	 concentrations	 (MIC)	 and	 Minimum	 bactericidal	 concentration	








Minimum	 inhibitory	 concentrations	 (MIC)	 and	 Minimum	 bactericidal	 concentration	 (MBC)	 for	 H.	
influenzae	 (HI)	 (strains	 ATCC	 33391,	 NT	 176	 and	 NT	 1159)	 in	 planktonic	 and	 biofilm	 antibiotic	
susceptibility	 respectively.	 MIC	 was	 assessed	 by	 E-test	 method	 with	 BHIs	 agar	 of	 H.	 influenzae	


















Amoxicillin:	 	 	 	 	
ATCC	 1.0	(S)	 1.0	(S)	 32	 32	
NT	176	 1.5	(S)	 2.0	(S)*	 32	 64*	
NT	1159	 1.0	(S)	 1.0	(S)	 32	 32	
Ciprofloxacin:	 	 	 	 	
ATCC	 0.008	(S)	 0.012	(S)*	 0.1	 0.1	
NT	176	 0.012	(S)	 0.012	(S)	 0.05	 0.1*	






This	 paper	 is	 the	 first	 study	 to	 our	 knowledge	 to	 establish	 that	 A.	 otitidis	 forms	 biofilm	 in	 vitro.	
Additionally,	we	demonstrated	that	A.	otitidis	and	H.	influenzae	form	polymicrobial	biofilm	and	that	
once	 in	 this	 form,	 these	 bacteria	 develop	 traits	 that	 promote	 persistence	 and	 recalcitrance	 to	
treatment.		
A.	otitidis	 is	 the	most	prevalent	bacterial	 species	 found	 in	patients	with	non-purulent	OME	 (20	 to	
40%)181-183.	 Our	 department	 recently	 confirmed	 this	 using	 culture-independent	 16S	 rRNA	
sequencing	 in	 two	 cohorts	 of	 children	 with	 COME336,342.	 In	 these	 studies,	 we	 also	 presented	
evidence	 that	 the	 external	 ear	 canal	 is	 likely	 the	 reservoir	 by	which	A.	 otitidis	 is	 seeded	 into	 the	
middle	 ear	 (via	 tympanic	 membrane	 perforation).	 In	 the	 past,	 A.	 otitidis	 has	 been	 considered	 as	
merely	a	 commensal	of	 the	external	ear	 canal38,175.	However,	 consensus	on	 the	 role	of	A.	otitidis	
remains	divided,	as	A.	otitidis	has	been	shown	to	have	pathogenic	traits	 including	eliciting	immune	
responses	 in	 vitro211-216,	 invading	 intracellularly188	 and	 having	 been	 identified	 as	 a	 pathogen	 in	
device	related217	and	chronic	infection219.	Furthermore,	during	phylogenetic	analysis	of	our	data	we	




form	biofilm	 is	 consistent	with	 this	perception	162.	 The	 life	 cycle	of	biofilms	 closely	 resembles	 the	
natural	history	of	OM,	which	is	characterized	by	frequent	spontaneous	resolution,	but	also	by	high	
recurrence	rates	and	persistence	of	bacteria	despite	antibiotic	treatment.	While	in	biofilm	form,	the	







and	 persistence	 advantage	 due	 to	 the	 protection	 conferred	 by	 the	 extracellular	 polysaccharide	
matrix.	 This	 matrix	 protects	 bacteria	 within	 against	 not	 only	 environmental	 (e.g.	 fluctuations	 in	
temperature,	 oxygen	 tension,	 pH)	 and	 chemical	 (e.g.	 antibiotics)	 stressors	 but	 also	 against	
phagocytosis	and	humoral	immunity280,281.		
In	 the	 setting	 of	 OM,	 biofilms	 were	 first	 demonstrated	 in	 the	 middle	 ear	 in	 an	 animal	 model	 of	
OM295,296.	Since	that	time,	middle	ear	biofilm	has	been	shown	in	patients	with	chronic	suppurative	
OM	 and	 cholesteatoma300.	 More	 recently,	 biofilm	 has	 been	 isolated	 on	 the	 surface	 of	
tympanostomy	 tubes301	 and	 also	 free	 floating	 within	 the	 middle	 ear	 aspirates	 of	 children	 with	
COME302.	 A	 further	 two	 studies	 have	 confirmed	 the	 presence	 of	 biofilm	 on	 middle	 ear	 mucosa	
(MEM)	 from	 children	 with	 COME.	 Using	 fluorescence	 in	 situ	 hybridisation	 (FISH)	 and	 SEM	 Hall-
Stoodley	 et	 al162	 demonstrated	 that	 92%	 of	 the	 children	 in	 their	 study	with	 COME	 and	 recurrent	
AOM	had	polymicrobial	MEM	biofilms,	70%	of	which,	were	 identified	as	 comprising	H.	 influenzae.	

















of	 this	 finding	 is	 that	 in	 the	 setting	 of	 OM	with	 effusion,	 polymicrobial	 biofilm	 formation	with	A.	
otitidis	 may	 result	 in	 the	 persistence	 of	 H.	 influenzae	 in	 biofilm	 during	 times	 of	 adverse	 growth	




co-cultured	with	H.	 influenzae	 biofilm.	 This	 indicates	 that	 the	 presence	 of	H.	 influenzae	 allows	A.	
otitidis	cells	to	overcome	the	growth	restrictions	it	incurs	when	grown	in	BHIs	media	(in	the	absence	
of	sheep	blood).	 It	will	be	 interesting	to	unravel	the	mechanism	of	this	observation	and	to	 identify	
putative	 factors	 produced	 by	 H.	 influenzae	 that	 may	 promote	 A.	 otitidis	 biofilm	 formation.	
Alternatively,	these	findings	could	indicate	that,	for	A.	otitidis	to	optimally	form	biofilm,	it	requires	a	
lattice	from	which	to	form	on.		
In	 addition,	 not	only	did	polymicrobial	 biofilm	 support	A.	 otitidis	 and	H.	 influenzae	 growth,	 it	was	
also	associated	with	an	increase	in	antibiotic	resistance	for	both	A.	otitidis	and	H.	influenzae.	Biofilm	
formation	is	regarded	as	providing	increased	antibiotic	resistance,	with	bacteria	in	biofilm	requiring	
antibiotic	 concentrations	multitudes	 higher	 to	 eradicate	 than	 for	 the	 same	 bacteria	 in	 planktonic	
form280,287.	 There	 is	 evidence	 in	 animal	 models	 to	 suggest	 that	 bacteria	 within	 a	 polymicrobial	
biofilm	can	confer	even	greater	protection	from	host	defences	and	antimicrobials	than	that	of	single-






impede	 antibiotic	 penetration,	 decreased	 metabolic	 activity	 of	 the	 bacteria	 within	 the	 biofilm,	
increased	 adaptation	 via	 quorum	 sensing,	 increased	 levels	 of	 mutations	 in	 antibiotic	 target	
molecules	and	upregulated	antibiotic	resistance	genes288.	
A.	otitidis	is	a	β-lactamase	negative	bacteria189,	and	while	being	resistant	to	vancomycin,	macrolides	
and	 trimethoprim189,220,221,	 it	 is	 known	 to	 be	 susceptible	 to	 penicillins,	 cephalosporins,	
tetracyclines189,220,	and	fluoroquinolones200.	While	little	is	known	about	resistant	A.	otitidis	strains,	
A.	otitidis	is	often	identified	within	middle	ear	aspirates	despite	antibiotic	treatment194.	In	contrast,	
14-65%	 of	 NTHi	 produce	 β	 lactamase246,	 with	 ampicillin	 resistance	 thought	 to	 be	 greater	 than	
30%350.	 In	 addition,	 emerging	 strains	of	NTHi	 also	possess	 a	 non	β	 lactamase	mediated	 ampicillin	
resistance,	 a	 trait	 originating	 from	 ftsl	 gene	 mutations250,	 which	 alter	 the	 structure	 of	 penicillin	
binding	 protein	 3.	 Antibiotic	 resistance	 gene	mutations	 and	 the	 transfer	 of	 these	 genes	 between	
bacterial	strains	has	been	identified	as	a	cornerstone	of	bacteria	evolving	antibiotic	resistance289.	As	
an	 example,	 studies	 have	 shown	 H.	 influenzae	 can	 horizontally	 transfer	 ftsl	 genes	 (and	 thus	
resistance	 traits)	 between	 bacterial	 strains290.	 	 Similarly,	 Armbruster	 and	 colleagues283	
demonstrated	 that	 polymicrobial	 biofilm	 formed	 by	 H.	 influenzae	 and	 Moraxella	 catarrhalis	
conferred	both	β	lactamase	dependent	and	β	lactamase-independent	resistance	to	each	other.		
In	our	study,	we	found	that	polymicrobial	biofilm	had	a	protective	effect	against	antibiotics	for	one	














was	added	 to	planktonic	 co-culture.	 Likewise,	planktonic	 cells	of	H.	 influenzae	 strains	NT1159	and	
ATCC	 33391	 showed	 decreased	 sensitivity	 to	 ciprofloxacin	 in	 the	 presence	 of	 A.	 otitidis.	 The	
significance	of	these	findings	is	not	clear	and	warrants	further	investigation.	Whilst	our	findings	were	
reproducible	 in	 at	 least	 3	 independent	 experiments,	 the	 E-test	 used	was	 not	 specifically	 designed	
and	validated	for	polymicrobial	sensitivity.	The	act	of	suspending	A.	otitidis	or	H.	influenzae	 in	agar	
for	the	E-test	may	indeed	alter	the	phenotype	of	these	bacteria,	thereby	altering	their	sensitivity	to	
antibiotics.	 In	 vivo	 studies	will	 likely	better	 replicate	physiological	 conditions	and	allow	 for	 further	
elucidation	of	these	relationships.	




mechanism	for	bacteria	 to	alter	 their	sensitivity	 to	antibiotics.	Further	studies,	both	 in	vitro	and	 in	
vivo,	exploring	the	ability	for	the	formation	of	polymicrobial	biofilm	with	clinical	isolates	of	A.	otitidis	










OM.	 We	 demonstrated	 that	 A.	 otitidis	 is	 capable	 of	 forming	 both	 single	 species	 and	 also	
























balance	 disorder	 in	 childhood.	 While	 there	 are	 many	 factors	 identified	 that	 contribute	 to	 the	
aetiology	of	OME,	bacteria	seem	to	play	a	prominent	role.		
In	 the	 past,	 identification	 of	 these	 bacteria	 was	 limited	 to	 their	 ability	 to	 be	 cultured	 in	 media.	
However,	these	techniques	had	an	inherent	bias	based	on	the	fact	that	bacteria	often	have	a	specific	
growth	requirement	and	that	fastidious	strains	were	unable	to	be	identified.	With	the	introduction	




of	16S	 rRNA	gene	 sequencing,	allowed	 researchers	 to	 identify	all	of	 the	microbes	within	a	 sample	
non-selectively.	This	technology	provided	researchers	with	a	greater	insight	into	the	pathogenesis	of	

















microbiota	 of	 the	 OME	 between	 patients.	 However,	 Aerococcus	was	 the	 most	 abundant	 genera	
(mean	 relative	 abundance	 23%),	 followed	 by	 Haemophilus	 (22%),	 Staphylococcus	 (11%),	
Corynebacterium	(6%),	Streptococcus	(5%)	and	Moraxella	(5%).	These	findings	were	consistent	with	
the	 findings	 previously	 published	 by	 Jervis	 Bardy	 et	 al.164	 and	 suggest	 that	 the	microbiota	 of	 the	
middle	ear	in	OME	is	consistent	between	different	demographic	and	geographical	groups.		
Additionally,	 we	 found	 that	 the	microbiota	 resident	 on	 the	 adenoid	 pads	 of	 control	 patients	 and	
those	 with	 OME	 were	 similar,	 which	 was	 contrary	 to	 expectation.	 The	 microbiotas	 were	 both	
dominated	 by	 the	 classic	 otopathogens	 (Haemophilus,	 Streptococcus	 and	 Moraxella),	 with	 high	
prevalence	 of	 anaerobes	 (predominantly	 Fusobacteria).	 These	 findings	 are	 consistent	 with	 the	
current	 understanding	 of	 the	 commensals	 of	 the	 nasopharynx,	 but	 also	 suggest	 that	 the	 bacteria	
colonising	 the	adenoid	pad	do	not	 change	 in	 the	presence	of	OME	and	 therefore	may	not	have	a	
significant	 influence	 on	 the	microbiota	 of	 the	middle	 ear	 in	 this	 setting.	 This	 concept	was	 further	
supported	 by	 the	 observation	 that	 the	 microbiota	 of	 the	 middle	 ear	 in	 OME	 was	 significantly	
dissimilar	to	that	of	the	adenoid	pad.	While	the	two	sites	shared	similar	abundances	of	Haemophilus,	













was	 a	 strong	 correlation	 between	 Aerococcus	 (A.	 otitidis),	 Staphylococcus,	 Pseudomonas	 and	
Corynebacteria.	This	finding	suggests	that	the	external	ear	canal	was	possibly	serving	as	a	reservoir	
for	 the	 middle	 ear,	 with	 bacteria	 likely	 translocating	 through	 perforations	 of	 the	 tympanic	
membrane,	 a	 precedence	 for	 which	 is	 seen	 in	 chronic	 suppurative	 otitis	 media	 being	 caused	 by	
primarily	external	ear	canal	bacteria.	
When	the	data	was	collated	from	both	studies,	we	found	that	the	microbiota	from	the	two	cohorts	
were	 similar.	 This	 finding	 intimates	 that	 there	 exists	 a	 core	microbiota	within	 the	middle	 ears	 of	
children	 with	 OME,	 consisting	 of	 Aerococcus,	 Haemophilus,	 Corynebacteria,	 Staphylococcus,	
Streptococcus	 and,	Moraxella,	 which	 appears	 to	 be	 stable	 over	 time	 and	 between	 populations.	
Moreover,	 the	 results	 suggested	 that	 both	 adenoid	 pad	 and	 external	 auditory	 canals	 act	 as	
reservoirs	 for	 the	 middle	 ear;	 the	 adenoid	 pad	 seeds	 the	 middle	 ear	 with	 Haemophilus,	
Streptococcus	and	Moraxella,	while	the	EAC	seeds	the	middle	ear	with	Aerococcus,	Corynebacteria	







We	set	about	exploring	 the	growth	characteristics	of	A.	otitidis,	 specifically	whether	A.	otitidis	 is	a	
biofilm	 forming	 bacteria.	 OME	 is	 a	 biofilm	 driven	 disease,	 as	 illustrated	 by	 the	 demonstration	 of	
polymicrobial	 biofilm	 on	 the	 middle	 ear	 mucosa	 of	 children	 with	 OME162,299.	 Therefore,	 we	
hypothesised	that	should	A.	otitidis	play	a	role	in	the	pathogenesis	of	OME,	it	is	likely	in	biofilm	form.	
In	 our	 in	 vivo	 experiments,	 using	 confocal	 laser	 scanning	 microscopy	 and	 scanning	 electron	
microscopy,	 we	 confirmed	 that	 A.	 otitidis	 formed	 biofilm.	 Additionally,	 when	 investigating	 the	
bacterial	 interactions	 between	 H.	 influenzae	 and	 A.	 otitidis,	 we	 found	 that	 A.	 otitidis	 formed	




We	 have	 described	 the	 bacterial	 communities	 that	 reside	 within	 the	middle	 ear	 in	 children	 with	
middle	 ear	 effusion	 with	 16S	 rRNA	 gene	 sequencing.	 However,	 next	 generation	 gene	 sequencing	
technology	 continues	 to	 evolve.	 Whilst	 this	 technology	 is	 considered	 novel	 in	 the	 field	 of	
otolaryngology,	 16S	 sequencing	 is	 now	 considered	 mainstream	 in	 medical	 research	 and	 science.	
Work	is	being	carried	out	by	researchers	to	not	only	identify	the	bacteria	within	the	samples	but	also	
the	entire	genomes	unique	 to	 those	bacteria.	 This	 is	 known	as	 the	 study	of	metagenomics,	which	
allows	 researchers	 to	 investigate	 the	 functional	 characteristics	 of	 the	 microbiome.	 Additionally,	
advanced	 techniques	 have	 also	 delved	 into	 characterising	 protein	 expression	 (metaproteomics),	
metabolites	 (metabolomics)	 and	mRNA	 products	 (metatranscriptomics).	When	 these	 technologies	






An	 example	 of	 the	 need	 for	 further	 clarifying	 the	 relationships	within	 the	microbiome	 is	with	 the	
interpretation	of	our	16S	rRNA	gene	sequencing	findings.	We	found	an	inverse	correlation	between	
A.	otitidis	and	H.	 influenzae.	 Initially,	we	had	hypothesised	that	this	 indicated	a	potential	for	direct	
bacterial	 interference	 between	 the	 two	 bacteria.	 However,	 we	 now	 believe	 that	 the	 inverse	
correlation	 found	 was	 likely	 a	 reflection	 of	 fact	 that	A.	 otitidis	 and	H.	 influenza	 require	 different	
growth	conditions.	We	hypothesise	that	the	environment	within	the	middle	ear	cleft	in	the	presence	
of	 a	 stable,	 non-purulent	 effusion,	 is	more	 conducive	 to	 the	 promotion	 of	A.	 otitidis	 growth	 and	
persistence.	 During	 this	 time,	H.	 influenzae,	 and	 potentially	 other	 otopathogens	 are	 promoted	 to	
persist	 in	 biofilm	 form	 in	 the	 presence	 of	 a	 high	 abundance	 of	 A.	 otitidis.	 However,	 subsequent	
changes	 in	 the	 local	 environment	 within	 the	 middle	 ear,	 whether	 via	 direct	 inflammation	 (for	
example,	 secondary	 to	 viral	 infection)	 or	 host	 immunomodulation,	 lead	 to	 an	 environment	more	
advantageous	to	H.	influenzae	proliferation.	The	result	is	the	emergence	of	H.	influenzae	as	the	more	
dominant	 species,	 thus	potentially	 resulting	 in	acute	disease.	As	discussed,	 there	 is	an	established	
chinchilla	model	of	otitis	media	and	biofilm295,296	that	may	be	suitable	to	explore	this	phenomenon	
further.	 Unfortunately,	 chinchillas	 are	 not	 readily	 available	 in	 Australia,	 yet,	 rat	 models	 of	 otitis	
media	exist	that	may	be	suitable	substitute	biofilm	model.		
Another	 limitation	 to	 our	 in	 vitro	 work	 lies	 in	 the	 limited	 number	 of	 strains	 that	 were	 tested.	
Unfortunately,	 we	were	 unable	 to	 obtain	 clinical	 isolates	 of	A.	 otitidis.	However,	we	 believe	 that	
applying	 clinical	 isolates	 of	 A.	 otitidis	 and	 greater	 numbers	 of	H.	 influenzae	 to	 our	 experimental	
model	 will	 further	 elucidate	 the	 role	 that	 this	 bacterium	 plays	 in	 OME.	 Furthermore,	 the	 inverse	








This	 thesis	 has	 made	 a	 significant	 contribution	 to	 our	 understanding	 of	 the	 complex	 role	 that	
bacteria	play	in	otitis	media	with	effusion	using	novel	molecular	sequencing	techniques.	In	addition,	
we	 have	 added	 to	 the	 growing	 evidence	 that	 A.	 otitidis,	 whether	 directly	 or	 indirectly,	 plays	 a	
pathogenic	role	in	OME.	
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